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Abstract 
Two flexidentate Schiff-base ligands condensed from salicylaldehyde or 5-
chlorosalicylaldehyde with N-(3-aminopropyl)morpholine were prepared in situ and 
reacted with zinc(II), copper(II) and nickel(II) salts. These compounds were characterised 
by elemental analyses and various physico-chemical techniques. Single crystal X-ray 
analyses were carried out on nine different complexes. Upon complexation, the Schiff 
bases underwent deprotonation at the hydroxyl to act as mono-anionic ligands. When a 
ligand:metal ratio of 2:1 was applied, the deprotonated Schiff bases coordinated metal ions 
through phenolate and imine groups in a square-planar or tetrahedral geometry. In contrast, 
5-chlorosalicylaldimine reacted with the metal ions in a 1:1 ratio to form complexes 
wherein morpholine nitrogen also participates in an N,N,O-tridentate coordination mode. 
The structures of the complexes were characterized by spectroscopic methods and single 
crystal X-ray diffraction.  
The Schiff bases and their metal complexes were evaluated for cytotoxic and 
antioxidant activity. Cytotoxic screening was carried out against human breast cancer cells 
with positive estrogen receptor (MCF-7), human breast cancer cells with negative estrogen 
receptor (MDA-MB-231), and colon cancer cell line (HT-29). This cytotoxicity also was 
tested on two normal cells, normal liver cells (WRL-68) and normal colon cell lines (CCD-
841). The Schiff bases L
1
H, was found to be very active against breast cancer with positive 
estrogen receptor cells and also colon cancer cells with the lowest IC50 values. Antioxidant 
screening was carried out by using ferric reducing antioxidant power (FRAP) assay. All 
compounds were found to have low activity except for L
1
H ligand with FRAP value higher 
than the standard BTH and Trolox. 
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Abstrak 
Dua bes Schiff ligan fleksibel yang disintesiskan daripada  kondensasi di antara 
salisilaldehid atau 5-klorosalisilaldehid dengan N-morfolina(3-aminopropil) telah 
disediakan secara in situ dan bertindak balas dengan garam zink(II), kuprum(II) dan 
nikel(II). Semua sampel telah dicirikan dengan menggunakan pelbagai teknik kimia-fizik. 
Analisis sinar-X telah berjaya dilakukan terhadap sembilan kompleks hablur tunggal yang 
berbeza. Kompleks bes Schiff terhasil dengan pendeprotonan kumpulan hidroksil dan 
bertindak sebagai ligan mono-anionik. Apabila nisbah ligan:logam 2:1 digunakan, bes 
Schiff ternyah proton akan berkoordinat dengan ion logam melalui fenolat dan imina dan 
mempunyai geometri empat segi satah atau geometri tetrahedron. Sebaliknya, kompleks 5-
klorosalisilaldehid bertindak balas dengan ion logam dengan nisbah 1:1, nitrogen morfolin 
akan mengambil bahagian berkoordinat melalui kaedah N,N,O. Struktur kompleks 
dicirikan menggunakan kaedah spektroskopi dan analisis sinar-X. 
Bes Schiff dan kompleks logam masing-masing telah diuji untuk menilai aktiviti 
sitotoksik dan anti-oksida. Analisis sitotoksik telah dilakukan ke atas beberapa jenis sel 
barah iaitu sel barah payu dara manusia dengan penerima estrogen positif (MCF-7), sel 
barah payu dara manusia dengan penerima estrogen negatif (MDA-MB-231) and sel barah 
kolon (HT-29). Analisis sitotoksik ini juga telah diuji ke atas dua sel normal iaitu sel hati 
(WRL-68) dan sel kolon (CCD-841). Terdapat satu bes Schiff L
1
H yang sangat aktif 
terhadap sel barah payu dara dengan penerima estrogen positif dan juga sel kanser kolon 
dengan nilai IC50 yang terendah. Saringan kereaktifan antioksida telah dijalankan dengan 
menggunakan keadah kuasa antioksida penurunan ferik (FRAP). Semua sebatian didapati 
mempunyai aktiviti yang rendah kecuali bagi ligan L
1
H yang mempunyai nilai FRAP lebih 
tinggi daripada BTH and Trolox. 
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1.0 INTRODUCTION 
1.1 Schiff bases 
The coordination chemistry of Schiff base ligands and transition metal ions has 
developed rapidly in the past decade. The ligand named after the researcher, Hugo Schiff 
reported his synthesis over hundred years ago (Wilkinson et. al., 1987). The attention on 
these ligands arose mainly due to their capability of producing the Schiff bases metal 
complexes with a variety of coordination modes. In addition, the resulting complexes have 
been under investigation for many years due to numerous applications, essentially in the 
treatment of cancer (Osowole et. al., 2012), as antimicrobial agents (Aminabhavi et. al., 
1985; Prasad et. al., 2010), fungicide agents (Mishra & Soni, 2008), antiviral agents (Wang 
et. al., 1990) and potential applications in other fields such as catalysts for many reactions 
(Rezaeifard et. al., 2010) and also electrochemistry (Tai et. al., 2003). The general 
structure of the Schiff base is portrayed in Figure 1.1. 
N
CR'
R
H
 
Figure 1.1: General structure of Schiff base. 
1.2 Chemistry of Schiff bases 
Schiff bases containing an azomethine or imine group (–C=N–) are commonly 
synthesized via the condensation of primary amines and active carbonyl compounds 
(Casellato & Vigato, 1977; Dey et. al., 1981). Condensation of these compounds is carried 
out in different reaction conditions and using common solvent such as methanol or ethanol. 
The general formation of azomethine group is shown according to Scheme 1.1. 
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R NH2 +
R' R"
O
R
N R'
R"
+ H2O
Primary
amine
Carbonyl Schiff base
R = alkyl or aryl substituents
Scheme 1.1: General formation of Schiff base. 
Schiff bases ligands that contain aryl substituent or aromatic aldehydes are 
substantially more stable and more readily synthesized. Whereby, the ligands containing 
alkyl substituents or aliphatic aldehydes are rather unstable and readily polymerizable 
(Hine & Yeh, 1967). Generally, Schiff bases with ketone are formed less readily than those 
with aldehydes, due to the extra carbon of ketone that donates electron density to the 
azomethine carbon. Hence, making the ketone less electrophilic compared to aldehyde 
(Fessenden & Fessenden, 1998). 
Normally, formation of Schiff base occurs either at room temperature, upon 
heating, in the presence of acid catalyst or base catalyst. Formation of an imine involves 
two steps. Firstly, the amine nitrogen acts as a nucleophile, attacking the carbonyl carbon, 
resulting in a normally unstable carbinolamine intermediate. Upon deprotonation of 
nitrogen and elimination of the hydroxyl group formed C=N (imine) and also displaced 
water molecule. The mechanism is depicted in Scheme 1.2. 
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R
NH2 C
R'
R"
O
NH C
R
R'
R"
OH
H+
Primary
amine
Carbonyl Carbinolamine
N
R
C
R"
R'
H2O+
N-substituted
imine
 
Scheme 1.2: Mechanism formation of Schiff base. 
Futhermore, the carbinolamine loses water by either acid or base catalysed 
conditions. Since the carbinolamine is alcohol, it undergoes acid catalysed dehydration as 
shown in Scheme 1.3. 
N C
R
R'
R"
OH
Carbinolamine
H+
N C
R
R'
R"
OH2
N C
R
R'
R"
H H
H
H2O+
N
R
C
R"
R'
H3O
+
+
N-substituted
imine
(acid catalyzed dehydration)
 
Scheme 1.3: Formation of Schiff base via acid catalysed dehydration.
Chapter 1| Introduction 
 
4 
 
1.3 Schiff base complexes 
Since the nineteenth century discoveries, a wide range of complexes derived from 
Schiff base ligands have been studied. Especially the transition metal complexes have 
played an important role in the development of modern coordination chemistry, due to 
various coordination modes. Transition metals have a different tendency to form 
complexes because of the presence of empty d orbitals to accept lone pairs of electrons 
from the ligand (Zumdahl & Zumdahl, 2008). Schiff base complexes also have a diverse 
biological functions, such as the haem group and vitamin B12 coenzyme which contain 
transition metal (Woollins, 2010). 
Metal complexes with chelating ligands containing N, S and O donor atoms have 
interesting versatility in coordination modes. For example, Schiff bases formed by 
condensation of salicylaldehyde with a primary amine are capable of coordinating metal 
ions. Metal coordination modes in these complexes involve phenolate oxygen and imine 
nitrogen to form six-membered chelate rings. If the amine fragment contains other donors 
located for coordination to metal, the Schiff base can act as a polydentate ligand or, 
depending on flexibility of the amine fragment, may show ambidentate behaviour. The 
Figure 1.2 shows some examples of tridentate and ambidentate Schiff base ligand. 
 
Chapter 1| Introduction 
 
5 
 
 
 
N
N
NH2
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H
2
O
H
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O
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N N
N
H
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O
 
Figure 1.2: Tridentate and ambidentate Schiff base ligands. 
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1.4 Cancer and cancer drugs 
Cancer remains a major cause of mortality worldwide. This disease is characterized 
by the uncontrolled multiplication of abnormal cells in the body (Gupta, 1994). Due to this 
disease, researchers all over the world are trying to find anticancer drugs that have fewer 
side effects to the human body. Since the 1940s, anticancer drugs have been developed and 
commercialized in the United State, Europe and Japan. However, every anticancer drug 
that has been developed to kill cancer cells will have affects prompting the normal cell 
division because cancer exhibits no biochemical differences to the healthy normal cells 
(Rang et. al., 1995). 
The inorganic metal complexes are used as chemotherapeutic agents although 
organic, non-metal containing agents are most widely employed. Complexes of transition 
metals are exploited as anticancer drugs due to their cytoxicity properties. Platinum drugs, 
such as carboplatin and cisplatin as shown in Figure 1.3 are proving effective against 
cancer cells. In addition, cisplatin are effective against ovarian cancers, testes cancers and 
other solid tumors (Howard-Lock & Lock, 1987). 
Pt
NH3
Cl
Cl
NH3  H3N
Pt
H3N
O
O
O
O  
Figure 1.3: Structure of cisplatin and carboplatin. 
1.4.1 Breast cancer 
According to the World Health Organization, more than 1.2 million people are 
diagnosed with breast cancer annually. This cancer initiated by various environmental 
and/or hereditary factors. Some of the usual symptoms of breast cancer are swelling at part 
of the breast, lump in the underarm area, skin irritation around the breast, nipple pain and 
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nipple discharge. The Malaysian Cancer Registry in 2003 had reported that breast cancer is 
the most commonly diagnosed cancer (31 %) in women (Lim and Halimah, 2004). 
Nevertheless, breast cancer death rates have been gradually decreasing due to better 
detection and easily treatments available. Recent studies reveal that breast cancer risk is 
dependent on several factors including genetic predisposition and menopause (Vogel, 
2008). Breast cancer is less common in younger females (<30 years old) but is generally 
more aggressive compared to older women. Therefore, the survival rates for younger 
breast cancer patients are lower. 
1.5 Antioxidants 
Antioxidants are compounds that inhibit the oxidation process through numerous 
mechanisms, such as by preventing the formation of reactive radical species or by 
scavenging them. Free radicals are chemical fragments of molecules that possess an 
unpaired electron and are continuously produced in cells during normal metabolism. Free 
radicals can cause extensive damage to macromolecular components like DNA, 
carbohydrates, lipids and protein if allowed to react uncontrollably. The levels of 
antioxidants and oxidants in the body are continuously maintained in homeostasis by 
dietary antioxidants and antioxidant enzymatic systems in the body. The imbalance of 
these systems has been claimed to cause chronic diseases over a sustained period, 
including cancer (Galli et. al., 2005) and coronary heart disease (Adams et. al., 1999). 
A free radical is very reactive and can be defined as element or compound that 
needs an electron to fill an unfilled molecular valence orbital. They often “attack” and 
remove electrons from the molecule in closest proximity which can be neutral, positively 
or negatively charged (Hughes et al., 1999). Oxygen can become a reactive molecule when 
oxygen is visible to a source of high energy, the energy is transferred to shape singlet 
oxygen (Ardestani et al., 2007). 
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O2  + Energy   O2• 
Normally, over 95% of the oxygen reduced to H2O by the electron transport system in 
the mitochondria: 
O2• + 4e
-
 + 4H
+
   2H2O 
When molecule oxygen is reduced by one electron, superoxide radical is produced: 
O2 + e
-   
 O2•
¯ 
After the second electron is added at physiologic pH, the two products of hydrogen 
peroxide (H2O2) and hydrogen peroxide are formed: 
2 O2•¯ 
 
+ 2H
+
  O2  +  H2O2 
O2•¯  +  H2O2  +  4H
+  
 O2  +  H2O  +  HO• 
The formation of HO• from H2O2 is catalyzed by transition metals such as  iron and 
copper. O2•¯, H2O2 and HO• are known as reactive oxygen species (ROS) and are 
continuously produced by aerobically growing cells (Castro & Hermandez-Aaron et al., 
2002). 
Dietary antioxidants (or non-enzymatic antioxidants) can be evaluated by several 
established techniques. Although the reagents and chemistry involved may differ in these 
procedures but the theory is based on redox chemistry and free radical discoloration. For 
instances, the ferric reducing antioxidant power (FRAP) assay (Benzie & Strain, 1996) is 
based on redox chemistry and the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical 
scavenging method (Oki et. al., 2002) was established on free radical discoloration. 
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Associated to dietary antioxidants, enzymatic antioxidant systems are natural 
mechanisms in our body that provide an endogenous method to overcome oxidative stress. 
For example, the glutathione peroxidase (GPx) enzyme, which is found in virtually all 
mammalian tissues, protects the body against the accumulation of free endogenous 
hydrogen peroxide. The GPx enzyme catalyzed the reaction by converting it to water to 
produce a non-toxic product. The oxidized glutathione molecule is stimulated by reduction, 
catalyzed by glutathione reductase. Functioning mutually, these two systems complement 
each other in maintaining homeostasis (Mills, 1957). Other examples of antioxidant 
enzymes particularly in the human liver are superoxide dismutase (SOD) and catalase 
(CAT) which catalyze the dismutation of superoxide into oxygen and hydrogen peroxide 
and also decomposition of hydrogen peroxide to water and oxygen, respectively 
(Greenwald, 1990; Muzykantov, 2001). 
Oxidation is a chemical reaction that transfers electrons from a substance to an 
oxidizing agent. Stray oxidation reactions can produce free radicals. These free radicals 
trigger chain reactions that could produce additional radical species that damage cells. 
Without the presence of antioxidants to sequester them, biomolecules are exposed to 
further radical oxidation. Hence, these lead to macromolecule alterations such as lipid 
peroxidation, enzymatic damage and DNA mutation. Accumulation of the yields of 
oxidative damage gives rise to oxidative stress which has been allied with the pathogenesis 
of many human diseases, such as Alzheimer's disease, Parkinson's disease, cancer, and 
aging (Valko et. al., 2007). 
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Figure 1.4: Illustration of oxidation reaction and antioxidant neutralizing free radical in 
human cell. 
 
In this thesis the determination of antioxidant activity are evaluated using Ferric 
Reducing Power Assay (FRAP) technique. 
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2.0 LITERATURE REVIEW 
2.1 Schiff bases 
In 1864, German chemist Hugo Schiff established a new class of organic 
compounds containing imine (azomethine) group. This group of compounds are often 
referred to as Schiff bases in his honour. Modern chemists still synthesizing Schiff bases 
ligands due to the activity and well-designed, as stated by Cozzi (2004) considered the 
ligand as ‘‘privileged ligands’’. These ligands can be considered an important class of 
organic compounds which are good chelating agent (Mishra et. al., 2005). Furthermore, 
Schiff bases are an important class of ligands in coordination chemistry and have been 
extensively studied (Eichhom et. al., 1994; Hughes, 1984; Tarafder et. al., 2001). 
Schiff bases are generally bidentate (1), tridentate (2), tetradentate (3) or 
polydentate (4) ligands capable of forming very stable complexes with transition metals. 
They can only act as chelating ligands if they bear a functional group, generally hydroxyl 
group. Sufficiently near the condensation site in such a way that a five or six membered 
ring can be formed when reacting with a metal ion. Additionally, Schiff bases with donors 
(N, O, S, etc.) have structural similarities with natural biological systems. The presence of 
imine group which are utilized in elucidating the mechanism of transformation and 
rasemination reaction in biological systems (Balasubramanian et. al., 2006). 
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OH
C
NR
R'  
OH
C
N
N
R"
R'
R
 
Bidentate (1) Tridentate (2) 
N N
RR
OH HO
 
CH3
C C
N
R
N
R
OH HO
OH
 
Tetradentate (3) Polydentate (4) 
Figure 2.1: Some examples of Schiff base ligands. 
Schiff bases appear to be essential intermediates in a number of enzymatic 
reactions involving interaction of the amino group of an enzyme, usually that of a lysine 
residue, with a carbonyl group of the substrate. Otto et. al., 1978 had conducted 
stereochemical studies with the support of molecular models showed that Schiff bases 
formed between methylglyoxal and the amino group of the lysine side chains of proteins 
can bend back in such a way towards the N atom of peptide groups. Hence, charge transfer 
can occur between the N atom of peptide groups and the oxygen atoms of the Schiff bases. 
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Schiff bases possess remarkable biological activities that have been reported in the 
literature as such antibacterial (Ali et. al., 2006), antifungal, anti-inflammatory (Turan-
Zitouni et. al., 2007), antitumor (Panneerselvam et. al., 2005) and anti HIV activities 
(Pandeya et. al., 2000). In 2003 Shamspur mentioned that Schiff bases are reagents which 
are becoming increasingly important in the pharmaceutical, dye and plastic industries as 
well as for liquid–crystal technology and mechanistic investigations of the drugs used in 
pharmacology, biochemistry and physiology. 
2.2 Schiff base complexes 
For a long period of time considerable attention has been paid to the chemistry of 
the Schiff base metal complexes containing nitrogen and other donors and it has become 
an emerging area of research. Several reviews have been discussed about the structure and 
mechanism of the formation of the Schiff base complexes. The review paper by Calligaris 
et. al. (1972) also deliberated on the stereochemistry of four coordinate chelate complexes 
formed from Schiff bases and their analogues. The configuration of the chelate group in 
the four coordinate complexes may be square-planar, tetrahedral, distorted tetrahedral or 
distorted trigonal pyramidal with the metal atom at the apex. The configuration depends 
predominantly on the nature of the metal ions and also on the magnitude, as well as the 
symmetry of the ligand field. All the Schiff base complexes, those derived from 
salicylaldimine have been thoroughly studied so far. A variety of physiochemical 
investigations on these complexes provide a clear understanding of their stereochemical 
and electronic properties. 
Various coordination modes of these compounds are useful models. Metal 
coordination modes in these complexes involve phenolate oxygen and imine nitrogen to 
form six-membered chelate rings. If the amine fragment contains other donors located for 
coordination to metal, the Schiff base can act as a polydentate ligand or, depending on 
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flexibility of the amine fragment, may show ambidentate behavior. As an example, the 
Schiff base derived from salicylaldehyde and N-(2-aminoethyl)piperazine (5) can be 
tetradentate or tridentate with nickel(II), depending on the piperazine ring conformation 
(chair or boat) (Mukhopadhyay et. al., 2003). The study also showed the profound 
influence of substitution in the aromatic ring on coordination behavior. Indeed, this 
research showed the ability of the ligand to act as both tridentate and tetradentate modes, 
the 5-nitroderivative (6), coordinated only in a tridentate, while the 5-bromo analog (7), 
only in a tetradentate fashion. 
Similar to piperazine, a morpholine ring in a ligand can adopt both chair and boat 
conformations, thus coordinating in different manners. An example is ligand 8 which has 
both chair and boat morpholine rings in its calcium complex (Poirier et. al., 2009). 
X
N N
NHOH
 
t
Bu
N
OH
N
O
O
 
5 : X = H 
6 : X = NO2 
7 : X = Br 
8 
Figure 2.2: Chemical diagram of ligands 5, 6, 7, and 8. 
Liu et. al. (2012) had conducted structural evidences and theoretical calculations on 
in situ ligand and Schiff base complex transformation. In this study, in situ organic 
reactions are an effective method since they could provide a remarkable opportunity not 
only to generate organic ligands to be synthesized under conventional conditions. 
Generally, the mechanism of in situ ligand transformation was ascribed to the coordination 
Chapter 2| Literature Review 
 
15 
 
effect, in which the metal ion will cause a decrease in electron density on the aromatic 
ring, hence activating the ligand. The coordination effect can also be caused by the metal 
ions which play a role of template to tune the arrangement of molecular components in the 
crystals, making them satisfy the condition of ligand transformation. This paper showed 
the mechanism of the in situ ligand transformation based on the C–C coupling reaction that 
has been achieved at room temperature.  The complex 9 were obtained by dissolving 2-(4-
hydroxyphenyl)aminoacetic acid, NaOH and salicylaldehyde (the molar ratio 1:1:1.5) in 
methanol and heated with constant stirring for two hours. The complex 10 were obtained 
from the reaction solution of complex 9 after a week of disappearance of the crystals of 
complex 9 when some more salicylaldehyde and NaOH were added to the solution of 
complex 9. 
 
 
 
Figure 2.3: Crystal Structure of complex 9 and complex 10. 
 
Scheme 2.1: The proposed mechanism of the in situ ligand transformation, C–C 
coupling.
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2.3 Biological Importance of Schiff Bases and the complexes 
The Schiff base metal complexes have been of great interest for many years due the 
chemistry and the biocidal activities of transition metal complexes containing O, N and S, 
N donor atoms. The transition metal complexes having oxygen and nitrogen donor Schiff 
bases possess unusual configuration, structural lability and are sensitive to molecular 
environment. The environment around the metal centre is the key role in the coordination 
of metals at the active sites of numerous metallobiomolecules (Golcu et. al., 2005). It has 
been shown that Schiff base complexes derived from 4-hydroxysalicylaldehyde and 
amines have strong anticancer activity, e.g., against Ehrlich ascites carcinoma (EAC) 
(Zishen et. al., 1993). Table 2.1 shows the summary of biological properties of several 
compounds related to these studies and Figure 2.4 illustrates chemical structures of the 
compounds. 
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Table 2.1: Biological application summary of several compounds. 
Compound Name Biological Application References 
Phendimentrazine (11) Appetite suppressants Sladojevich et. al., 2008 
(2S,3S,5R)-2-(3,5-Difluorophenyl)-3,5-dimethyl-2-
morpholinol (12) 
Antidepressant agent and selective inhibitor of norepinephrine 
uptake 
Kelley et. al., 1996 
2-(4-methyl-2-phenylmorpholin-2-yloxy)ethyl 
nitrate (13) 
Antioxidants activity Guillonneau et. al., 2003 
Heterocyclic piperazines (14) Numerous physiological effects, including accelerated pulse 
and breathing and hypersensitivity to external stimuli  
Prelog & Driza, 1933 
Ipsapirone (15) Antidepressant Broekkamp et. al., 1995 
Buspirone (16) Anxiolytic drug  
Mahmood & Sahajwalla, 
1999 
Indinavir (17) 
The HIV protease inhibitor indinavir, compound that blocks 
farnesyltransferase activity (anti-cancer)  
Rossen et. al., 1995 
Rawls, 1998 
N-benzylidine-2-morpholoinobenzenamine (18) Analgesic and antiinflammatory activities Panneerselvam et. al., 2009 
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Compound Name Biological Application References 
N-(3-nitrobenzylidine)-2-morpholino benzenamine 
(19)  
Anti-microbial activity against S. aureus,  E. coli and C. 
albicans  
Panneerselvam et. al., 2009 
Salicylaldehyde thiosemicarbazone (20) Antiproliferative activity potential antitumor agents 
Lovejoy & Richardson, 
2002 
Salicylaldehyde 4-phenylthiosemicarbazone (21) Display stronger antiproliferative activity than the parent 
compound 20 
 Dilovic´ et. al., 2008 
Schiff base copper complexes of quinoline-2 
carboxaldehyde (22) 
Inhibited chymotrypsin-like proteasome activity in intact 
prostate LNCaP cancer cells 
Adsule et. al., 2006 
2-[(2,3-dihydro-1H-inden-4-ylimino)methyl]-5-
nitrophenol (23) and its Schiff base complexes 
[ML2] (24) 
Where, M= Pd or Zn 
Pd(II) complex has the best anticancer activity against MCF-7 
cells which is close to the activity of cis platin 
Zn(II) complex and the ligand have broad spectrum activity like 
gentamycin 
 
Osowole et. al., 2012 
1-[(2-piperidin- 
1ylethylimino)methyl]naphthalen-2-ol) (25) 
Antibacterial activities against E. coli and S. aureus Sang & Lin, 2010 
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Compound Name Biological Application References 
Schiff base Cu(II) complex   (26) Antibacterial activities against E. coli, P. fluorescens, and S. 
aureus of the complex are superior to the Penicillin 
Sang & Lin, 2010 
Copper(II) complexes derived from 1-[(2-
morpholin-4-ylethylimino)methyl]-naphthalen-2-ol 
(28) 
Stronger activities against the bacteria then its ligand (27) Sang et. al., 2009 
Schiff base Ni(II) complexes derived for piperazine 
and salicylaldehyde analogue (29) 
Highly active in catechol oxidase activity positive charged 
ligand system supposed to be instrumental for their catecholase-
like activity 
Guha et. al., 2013 
4-chloro-2-[(2-morpholin-4-
ylethylimino)methyl]phenol (30) 
Activity against  Gram-negative bacterial strains (E. coli and P. 
fluorescence) 
Sang et. al., 2010 
Wang et. al., 2010 
Schiff-base Zn(II) complex (31) Bactericidal activities against the Gram-positive (B. subtilis and 
S. aureus) and Gram-negative bacteria (E. coli and P. 
fluorescence) similar or more patent with commercial 
antibiotics (kanamycin and penicillin) 
Wang, 2010 
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Figure 2.4: Chemical structures of the biologically active compounds.  
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These complexes play an important role in the development of coordination 
chemistry and have received much attention in recent years (Paschke et. al., 2003). Some of 
the complexes have been found to have pharmacological properties (You et. al., 2006). 
These unusual structural features have led to increased interest in the synthesis of copper, 
nickel and zinc complexes with various ligands (Sun et. al., 2006). Previous studies showed 
a morpholine ring in a bis(morpholinomethyl)phenoxy ligand upon complexation can adopt 
both tridentate and tetradentate modes, depends on the conformation of the mopholine ring 
either chair or boat conformation (Poirier et. al., 2009). 
The present studies were focused on the Schiff bases derived from salicylaldehyde 
derivatives and aliphatic amine, N-(3-aminopropyl)morpholine. Upon reacting the Schiff 
base with metal salts in a 2 : 1 ratio (ligand : metal), the ligands showed N,O-bidentate 
fashion. Whereas, the ligands with metal salts in a 1 : 1 ratio showed coordination N,N,O-
tridentate behaviour of the morpholine. Herein, we describe the behaviour of the two 
flexidentate ligands: salicylaldehyde, L
1
H and its 5-chlorosalicylaldimine analogue, L
2
H 
(Figure 2.5), towards zinc(II), copper(II) and nickel(II) ions. The solid-state structures of the 
metal complexes were examined by X-ray diffraction analysis. The complexes and ligands 
were also tested for their in vitro cytotoxicity and antioxidant properties. 
N N
OHX
O
 
L
1
H: X = H 
L
2
H: X = Cl 
Figure 2.5: Chemical diagram of L
1
H and L
2
H.
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2.4 Aims and objectives of the present study 
Generally, the aims of this research include synthesis, characterization and determine 
biological properties of the new Schiff bases of morpholine analogue with salicylaldehyde 
derivatives and their metal complexes. 
Specific, objectives of the research are: 
1. To synthesize Schiff bases of salicylaldehyde derivatives and aliphatic amine, N-(3-
aminopropyl)morpholine compounds. 
2. To prepare metal complexes from the synthesize Schiff base with zinc(II),copper(II), 
and nickel(II) ions. 
3. To elucidate the compounds structure using spectroscopic data such as elemental 
analysis (CHN), fourier transform-infrared (FT-IR), nuclear magnetic resonance 
(
1
H & 
13
C NMR), and UV-visible (UV-vis). 
4. To determine the solid-sate structures of the complexes, studied by X-ray diffraction 
analysis. The X-ray crystallographic data and structural determination help to 
examine the flexibility of the Schiff base compounds.   
5. To determine the biological properties such as cytotoxicity and anti-oxidant 
activities of the Schiff base ligands and their metal complexes. 
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3.0 EXPERIMENTAL 
3.1 Materials 
All the reagents used were commercially available (Merck, Acros or Sigma-Aldrich) 
and were used as supplied. Ethanol was distilled prior to use. All chemicals were of 
analytical grades and used without any further purification. Chemicals and solvents used for 
the preparation of Schiff base ligands and metal complexes are: N-(3-aminopropyl) 
morpholine, salicylaldehyde, 5-chlorosalicylaldehyde, zinc(II) acetate dehydrate 
[Zn(CH3COO)2·2H2O], copper(ІI) acetate monohydrate [Cu(CH3COO)2·H2O], nickel(II) 
acetate tetrahydrate [Ni(CH3COO)2·4H2O], zinc(II) chloride [ZnCl2], copper(II) chloride 
dehydrate [CuCl2.2H2O], nickel(II) chloride [NiCl2], triethylamine, ethanol, methanol, 
tetrahydrofuran (THF), and dimethyl sulphoxide (DMSO).  
The materials of biological studies are potassium ferricyanide K3[Fe(CN)6], 
trichloroacetic acid, ferric chloride solution and sodium phosphate from Sigma Chemical 
Co. (St. Louis, MO, USA). The solvents used are methanol and water (HPLC) were 
purchased from Chemolab Supplies (Kuala Lumpur, Malaysia). The instruments used for 
biological determination are an ELISA reader (Sunrise, Switzerland) and UV-vis 
spectrophotometer-1700 (Shimadzu, Japan) were used for absorbance determinations. 
3.2 Experimental Instruments 
A variety of physico-chemical methods have been employed to characterize the 
structure of the Schiff base ligands and their metal chelates. A brief account of these 
methods is given below. 
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3.2.1 Elemental analyses 
Microanalysis of carbon, hydrogen and nitrogen composition in the all the synthesized 
compounds were analyzed on a Perkin- Elmer 2400 Series II CHNS Analyzer.  
 
3.2.2 Fourier Transform-infrared (FT-IR) spectroscopy 
Infrared spectra for the synthesized ligands were recorded using NaCl cells and the 
synthesized complexes were recorded using KBr pellets on Pelkin-Elmer RX1 FTIR 
(Fourier Transform Infra-Red) spectrometer for frequencies 4000-400cm
-1
 at ambient 
temperature. 
 
3.2.3 Nuclear Magnetic Resonance (NMR) spectra 
All the ligands and zinc complexes 
1
H and 
13
C NMR spectra were recorded in DMSO-d6 on 
Bruker AVN 400 MHz FT-NMR or Lambda JEOL 400 MHz FT-NMR spectrometer with 
tetramethylsilane (TMS) as an internal standard. 
 
3.2.4 UV-Visible spectra 
The electronic spectra were measured by means of a Shimadzu 1601 spectrophotometer in 
the region 200–1100 nm using THF or DMSO as a solvent. The measurement using 1 cm 
quartz cuvettes with these following parameters: measuring mode, absorbance; scan speed, 
medium and the concentration of the samples is 1 × 10
-6
 M.  
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3.2.5 X-ray crystallography data and structural determination 
Diffraction data were measured with a Bruker SMART Apex II CCD area-detector 
diffractometer (graphite-monochromated Mo-Kα radiation, λ = 0.71073 Å). The orientation 
matrix, unit-cell refinement, and data reduction were all handled by the Apex2 software 
(SAINT integration, SADABS absorption correction (Bruker, 2007)). The structures were 
solved using direct or Patterson methods in the program SHELXS-97 and were refined by 
the fullmatrix least-squares method on F
2
 with SHELXL-97 (Sheildrick, 2008). All the non-
hydrogen atoms were refined anisotropically and all the C-bound hydrogen atoms were 
placed at calculated positions and refined isotropically. O-bound hydrogen atoms were 
located in difference Fourier maps and refined with distance restraints of O-HMethanol 0.84(2) 
and O-Hwater 0.88(2) Å. Drawings of the molecules were produced with XSEED (Barbour, 
2001). 
3.3 General Preparation of ligands and their complexes 
3.3.1 Schematic diagram of the Schiff bases 
O
N NH2 H
HO
X
O
+ Condensation
-H2O
O
N N
HO
X
X = H, Cl
 
3.3.2 Schematic diagram of the Schiff base complexes 
O
N N
HO
X
+ M2+
Condensation
X = H, Cl
O
N N
O
X
M
YY = Cl, acetate (OAc)
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3.4 Synthesis of Schiff bases 
 Two ligands (L
1
H, and L
2
H) were prepared by the reaction of N-(3-aminopropyl) 
morpholine with two different aldehydes (salicylaldehyde and 5-chlorosalicycladehyde). 
3.4.1 L
1
H: (E)-2-((3-morpholinopropylimino)methyl)phenol 
O
N N
HO
Chemical Formula: C14H20N2O2
F
igure 3.1: Proposed chemical structure of L
1
H. 
The compound was synthesized by refluxing a mixture of N-(3-aminopropyl) 
morpholine (0.35 g, 2.46 mmol) and salicylaldehyde (0.3 g, 2.46 mmol) in ethanol (15 mL) 
for 2 hours. The solvent was then removed under reduced pressure to give a yellow oil of the 
Schiff base.  
Anal. Calcd. for C14H20N2O2: C, 67.71%; H, 8.12%; N, 11.28%. Found: C, 66.79%; H, 
7.79%; N, 10.77%. IR [  max (cm
-1
), NaCl cell]: 3525 br; 2948 m; 2853 m; 2810 m; 1630 s 
( C=N); 1460 s; 1279 s; 759 m. 
1
H NMR (DMSO-d6,  ppm): 1.78 (quin, 2H, CH2); 2.32 (m, 
6H, CH2); 3.56 (t, 4H, CH2); 3.61 (t, 2H, CH2); 6.90 (m, 2H, Ar-H); 7.32 (t, 1H, Ar-H); 7.42 
(d, 1H, Ar-H); 8.55 (s, 1H, HC=N); 13.65 (s, 1H, OH). 
13
C NMR (DMSO-d6,  ppm): 
27.11, 53.29, 55.74, 56.20, 66.13 (CH2); 116.49, 118.29, 118.51, 131.51, 132.18 (Ar); 
160.91 (HC=N); 165.84 (C-OH). 
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3.4.2 L
2
H: (E)-4-chloro-2-((3-morpholinopropylimino)methyl)phenol 
O
N N
HO
Chemical Formula: C14H19ClN2O2
Cl
 
Figure 3.2: Proposed chemical structure of L
2
H. 
An equimolar mixture of N-(3-aminopropyl)morpholine(0.35 g, 2.46 mmol) and 5-
chlorosalicycladehyde (0.39 g, 2.46 mmol) in ethanol (15 mL) was refluxed for 2 hours. The 
solvent was then removed under reduced pressure to give a yellow oil of L
2
H ligand. 
Anal. Calcd. for C14H19ClN2O2: C, 59.47%; H, 6.77%; N, 9.91%. Found: C, 60.63%; H, 
7.07%; N, 10.12%. IR [  max (cm
-1
), NaCl cell]: 2950 m; 2853 m; 2810 m; 1636 s 
( C=N); 1483 s; 1279 s; 822 m; 697 m. 
1
H NMR (DMSO-d6,  ppm): 1.78 (quin, 2H, CH2); 
2.32 (m, 6H, CH2); 3.56 (t, 4H, CH2); 3.62 (t, 2H, CH2); 6.88 (d, 1H, Ar-H); 7.33 (dd, 1H, 
Ar-H); 7.53 (d, 1H, Ar-H); 8.53 (s, 1H, HC=N), 13.75 (s, 1H, OH). 
13
C NMR (DMSO-d6,  
ppm): 26.90, 53.27, 55.65, 55.92, 66.12 (CH2); 118.76, 119.39, 121.37, 130.43, 131.94 (Ar); 
160.28 (HC=N); 164.77 (C-OH). 
3.5 Synthesis of the metal complexes 
For the preparation of the metal complexes, the Schiff base ligands, L
1
H and L
2
H, were 
synthesized in situ by refluxing the solutions of N-(3-aminopropyl) morpholine (0.35 g, 2.46 
mmol) with either salicylaldehyde (0.3 g, 2.46 mmol) or 5-chlorosalicycladehyde (0.39 g, 
2.46 mmol) in ethanol or methanol (15 mL) for 2 hours. The resulting solutions were then 
used for the metal complexation reactions. 
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3.5.1 [Zn(L
1
)2] 
O
N N
O
O
N
N
O
Zn
Chemical Formula: C28H38N4O4Zn
Fi
gure 3.3: Proposed structure for [Zn(L
1
)2]. 
To a solution of the in situ prepared L
1
H in ethanol, a few drops of triethylamine 
were added followed by addition of a solution of Zn(OAc)2·2H2O (0.27 g, 1.23 mmol) (OAc 
stands for acetate) in ethanol. The mixture was refluxed for 1 hour. The solvent was then 
removed under reduced pressure to give yellow oil product which crystallized from 
methanol at room temperature.  
Yield: 0.58 g, 84.1%. Anal. Calcd. for C28H38N4O4Zn: C, 60.05%; H, 6.84%; N, 10.00%. 
Found: C, 60.25%; H, 7.05%; N, 10.03%. IR [  max (cm
-1
), KBr disc]: 2938 w; 2851 w; 
1626 s ( C=N); 1463 m; 1317 m; 759 m; 601 w; 462 w. 
1
H NMR (DMSO-d6,  ppm): 1.24 (s, 
1H, CH2); 1.67 (m, 2H, CH2); 2.12 (m, 6H, CH2); 2.20 (t, 2H, CH2); 2.33 (m, 1H, CH2); 3.60 
(t, 2H, CH2); 6.50 (s, 1H, Ar-H); 6.64 (d, 1H, Ar-H); 7.27 (m, 2H, Ar-H ); 8.47 (s, 1H, 
HC=N). 
13
C NMR (DMSO-d6,  ppm): 26.65, 52.90, 54.89, 57.87, 66.02 (CH2); 113.96, 
118.07, 122.27, 134.43, 135.97 (Ar); 169.77 (HC=N); 171.90. 
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3.5.2 [Zn(L
1
)Cl2] 
O N N
OZn
Cl
Chemical Formula: C14H19ClN2O2Zn
Fi
gure 3.4: Proposed structure for [Zn(L
1
)2Cl2]. 
An ethonolic solution of zinc(II) chloride (0.34 g, 2.46 mmol) were added to a 
solution of the in situ prepared L
1
H in ethanol (15 mL). The resulting solution was refluxed 
for 30 minutes, then the solvent was removed under reduced pressure. The impure product 
was recrystallized from methanol to give the yellow crystals. 
Yield: 0.51 g, 81.3%. Anal. Calcd. for C28H38N4O4Zn: C, 43.72%; H, 5.24%; N, 7.28%. 
Found: C, 43.73%; H, 4.89%; N, 7.24%. IR [  max (cm
-1
), KBr disc]: 3397 br; 2963 w; 
2857 w; 1636 s ( C=N); 1445 s; 1303 s; 755 s; 564 m; 465 w. 
1
H NMR (DMSO-d6,  ppm): 
2.09 (m, 2H, CH2); 2.53 (m, 4H, CH2); 2.84 (m, 4H, CH2); 3.60 (m, 4H, CH2); 6.98 (m, 2H, 
Ar-H); 7.29 (br, 1H, N-H); 7.53 (m, 1H, Ar-H ); 7.66 (dd, 1H, Ar-H ); 10.26 (s, 1H, HC=N). 
13
C NMR (DMSO-d6,  ppm): 23.37, 30.64, 53.05, 65.57, 65.99 (CH2); 117.19, 118.45, 
119.47, 122.24, 129.27 (Ar); 136.39 (HC=N); 191.81. 
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3.5.3 [Cu(L
1
)2] 
O
N N
O
O
N
N
O
Cu
Chemical Formula: C28H38CuN4O4
Fi
gure 3.5: Proposed structure for [Cu(L
1
)2]. 
A few drops of triethylamine were added to a solution of the in situ prepared L
1
H in 
methanol at room temperature. A methanolic solution of Cu(OAc)2·H2O (0.25 g, 1.23 mmol) 
was added and the mixture was stirred at room temperature for two hours. It was then set 
aside for two weeks whereupon the x-ray quality crystals of the copper complex were 
obtained.  
Yield: 0.60 g, 87.4%. Anal. Calcd. for C28H38N4O4Cu: C, 60.25%; H, 6.86%; N, 10.04%. 
Found: C, 60.25%; H, 7.05%; N, 10.03%. IR [  max (cm
-1
), KBr disc]: 2954 w; 2851 w; 
2801 w; 1613 s ( C=N); 1445 s; 1330 s; 760 s; 609 w; 456 w. UV-Vis [ max (nm), THF ( , 
mol
-1
dm
3
cm
-1
)] 245 (37185); 295 (7363); 307 (10158); 363 (11836); 619 (112). 
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3.5.4 [Ni(L
1
)2] 
O
N N
O
O
N
N
O
Ni
Chemical Formula: C28H38N4NiO4
Fi
gure 3.6: Proposed structure for [Ni(L
1
)2]. 
The complex was prepared by mixing equimolar of the Schiff base ligand with a 
solution of nickel chloride and was left stirring overnight. Successive 24 hours of stirring 
followed by solvent evaporation under reduced pressure to give viscous oil, then gradual 
addition of distilled water yielded the nickel complexes as green solids. Diffraction quality 
crystals of [Ni(L
1
)2] was obtained by slow evaporation of methanol solution of the complex 
at ambient temperature. 
Yield: 0.72 g, 82.3%. Anal. Calc. for C28H38N4O4Ni: C, 60.78; H, 6.92; N, 10.13. Found: C, 
60.63; H, 7.07; N, 10.12%. IR [  max (cm
-1
), KBr disc]: 2957 w; 2851 w; 1607 s ( C=N); 
1447 s; 1332 s; 757 s ; 599 m; 470 m. UV-Vis [ max (nm), THF ( , mol
-1
dm
3
cm
-1
)] 245 
(19703); 266 (13028); 326 (3312); 413 (1751); 614 (75). 
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3.5.5 [Zn(L
2
)2]·3H2O 
O
N N
O
O
N
N
O
Zn
Cl
Cl
Chemical Formula: C28H36Cl2N4O4Zn
F
igure 3.7: Proposed structure for [Zn(L
2
)2]·3H2O. 
The complex was prepared following the same procedure as for the preparation of 
[Zn(L
1
)2] except for using L
2
H (0.39 g, 2.46 mmol) as the ligand. Yellow crystals, suitable 
for single crystal X-ray diffraction analysis were obtained by slow evaporation of an ethanol 
solution of the complex at room temperature. 
Yield: 0.57 g, 67.6%. Anal. Calcd. for C28H42Cl2N4O7Zn: C, 49.24%; H, 6.20%; N, 8.20%. 
Found: C, 49.24%; H, 6.19%; N, 8.20%. IR [  max (cm
-1
), KBr disc]: 3340 br ( H2O); 2959 
w; 2852 w; 2822 w; 1618 s ( C=N); 1461 s; 1296 s; 832 m; 716 s; 552 w; 476 w. 
1
H NMR 
(DMSO-d6,  ppm): 1.24 (s, 1H, CH2); 1.63 (m, 2H, CH2); 2.12 (m, 6H, CH2); 2.20 (t, 2H, 
CH2); 2.33 (m, 1H, CH2); 3.55 (m, 2H, CH2); 6.66 (d, 1H, Ar-H); 7.25 (dd, 1H, Ar-H); 7.36 
(d, 1H, Ar-H); 8.47 (s, 1H, HC=N). 
13
C NMR (DMSO-d6,  ppm): 26.65, 52.65, 54.95, 
58.10, 66.00 (CH2); 116.60, 118.84, 124.20, 133.93, 134.04 (Ar); 168.44 (HC=N); 170.96. 
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3.5.6 [Zn(L
2
)(OAc)] 
O N
N
O
Zn
Cl
AcO
Chemical Formula: C16H21ClN2O4Zn
Fi
gure 3.8: Proposed structure for [Zn(L
2
)(OAc)]. 
An ethanolic solution of Zn(OAc)2·2H2O (0.54 g, 2.46 mmol) was added to an in situ 
prepared ligand (L
2
H) solution in ethanol (15 mL). The mixture was refluxed for two hours 
and then was left undisturbed at room temperature for two days whereupon X-ray quality 
crystals of the complex were obtained.  
Yield: 0.54 g, 58.7%. Anal. Calcd. for C16H23N2O4ClZn: C, 47.31%; H, 5.21%; N, 6.90%. 
Found: C, 47.43%; H, 5.05%; N, 6.85%. IR [  max (cm
-1
), KBr disc]: 2928 w;  2847 w; 
1646 s ( C=N); 1577 s; 1461 s; 1314 s; 850 s; 703 s; 559 m; 470 m. 
1
H NMR (DMSO-d6,  
ppm): 1.22 (s, 1H); 1.84 (m, 6H); 2.13 (m, 2H); 2.71 (br, 2H); 3.66 (m, 6H); 6.63 (d, 1H, Ar-
H); 7.16 (d, 1H, Ar-H); 7.25 (s, 1H, Ar-H); 8.29 (s, 1H, HC=N). 
13
C NMR (DMSO-d6,  
ppm): 21.69 (CH3)acetate; 25.51, 53.76, 53.76, 58.52, 58.91, 65.12 (CH2); 116.19, 118.99, 
124.22, 133.42, 133.73 (Ar); 168.38 (HC=N); 168.85 (C=O)acetate. 
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3.5.7 [Cu(L
2
)2] 
O
N N
O
O
N
N
O
Cu
Cl
Cl
Chemical Formula: C28H36Cl2CuN4O4
F
igure 3.9: Proposed structure for [Cu(L
2
)2]. 
To a methanolic solution (15 mL) of an in situ prepared L
2
H, a few drops of 
triethylamine were added followed by addition of a methanolic solution of Cu(OAc)2·H2O 
(0.25 g, 1.23 mmol) at ambient temperature. During the addition, a dark green precipitate 
was formed. The precipitate was filtered off and the filtrate was left undisturbed at room 
temperature. After one week, the X-ray quality crystals were collected by filtration, washed 
with cold methanol and air dried. 
Yield: 0.52 g, 68.1%. Anal. Calcd. for C28H36Cl2N4O4Cu: C, 53.63%; H, 5.79%; N, 8.93%. 
Found: C, 53.56%; H, 5.82%; N, 8.91%. IR [  max (cm
-1
), KBr disc]: 2951w; 2858 w; 2808 
w; 1624 s ( C=N); 1455 s; 1312 m; 834 s; 720 s; 560 m; 478 w. UV-Vis [ max (nm), THF ( , 
mol
-1
dm
3
cm
-1
)] 246 (38735); 295 (8313); 307 (9157); 374 (9819); 597 (115). 
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3.5.8 [Cu(L
2
)Cl]·CH3OH 
O
N
N
OCu
ClChemical Formula: C14H18Cl2CuN2O2
Cl
F
igure 3.10: Proposed structure for [Cu(L
2
)Cl]·CH3OH. 
A methanolic solution of CuCl2 2H2O (0.42 g, 2.46 mmol) was added to an in situ 
prepared L
2
H
 
in methanol (15 mL) at room temperature. The mixture was stirred for 1 hour, 
and then left undisturbed at room temperature. The crystals suitable for crystallographic 
analysis were obtained after one week. 
Yield: 0.71 g, 70.1%. Anal. Calcd. for C15H22N2O3Cl2Cu: C, 43.64%; H, 5.37%; N, 6.79%. 
Found: C, 43.30%; H, 4.69%; N, 7.23%. IR [  max (cm
-1
), KBr disc]: 3440 m. ( OH); 2942 
w; 2872 w; 1625 s ( C=N); 1460 m; 1316 m; 1024 s; 850 m; 703 s; 562 w; 470 w. UV-Vis 
[ max (nm), THF ( , mol
-1
dm
3
cm
-1
)] 247 (22413); 295 (4932); 353 (6165); 377 sh; 559 
(265); 772 (116). 
 
 
 
 
 
 
Chapter 3| Experimental 
 
38 
3.5.9 [Ni(L
2
)2] 
O
N N
O
O
N
N
O
Ni
Cl
Cl
Chemical Formula: C28H36Cl2N4NiO4
 
Figure 3.11: Proposed structure for [Ni(L
2
)2]. 
 
A few drops of triethylamine were added to a solution of the in situ prepared L
2
H in 
ethanol (15mL) at ambient temperature. An equimolar ethanolic solution of 
Ni(CH3COO)2·4H2O (0.31 g, 1.23 mmol) was added and the mixture was continued 
refluxing for one hour. The resulting mixture was left undisturbed at room temperature. The 
impure product was recrystallized from methanol to give green single crystal suitable for X-
ray diffraction analysis. 
0.49 g, 64.1 %. Anal. Calc. for C28H36N4O4Cl2Ni: C, 54.05; H, 5.83; N, 9.00. Found: C, 
53.96; H, 5.83; N, 8.91%. IR [  max (cm
-1
),KBr disc]: 2952 w; 2925 w; 2850 w; 1614 s 
( C=N); 1461 s; 1323 m; 822 s; 731 s; 549 w; 461 w. UV-Vis [ max (nm), THF ( , mol
-
1
dm
3
cm
-1
)] 257 (18190); 290 (10191); 337 (9164); 415 (4897); 619 (79). 
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3.6 Biological Screening Assay 
3.6.1 Cytotoxicity assay 
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay is 
an indirect colorimetric assay to assess the number of viable cells which has been adapted to 
measure the growth modulation of cells in vitro. The assay measures the amount of purple 
MTT formazan salt produced from metabolically cleaved yellow MTT tetrazolium salt. It 
has been established previously that the amount of MTT formazan salt produced is 
proportional to the amount of viable cells (Mosmann, 1983). The MTT formazan salt is 
dissolved in appropriate solvents and quantified spectrophotometrically. 
The assay was adapted to 96-well plates. The cancer cells and normal cells per well 
was seeded one day before the introduction of test samples to allow for cell attachment. 
Cells were either seeded in 90 or 180 μl of growth media and treated with 10 or 20 μl of test 
compound, respectively. Vehicle dimethyl sulfoxide (DMSO) was used as a control. The test 
samples were prepared 10X more concentrated to account for the dilution. The cells were 
treated with the samples for 48 hours. At the end of treatment, 10 % (v/v) of MTT (5 mg/ml) 
was added into each well and incubated for 4 hours at 37 °C. The medium was then gently 
aspirated, and 150μl dimethyl sulfoxide (DMSO) was added to dissolve the formazan 
crystals. The amount of formazan product was measured spectrophotometrically at 570 nm 
(OD readings were referenced to 650 nm to eliminate background signals.). Cytotoxicity of 
compounds was tested against four different types of human cancer cell lines and one normal 
cell line. The cancer cell line are breast carcinoma (MCF-7 and MDA-MB-213) and colon 
carcinoma (HT-26), and leukimia (JURKAT). Whereas, the normal liver cells (WRL-68) 
and normal colon cells (CCD-841) are used to test the toxicity of the compound on healthy 
cell. 
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Growth inhibition of cells was calculated according to the following formula. A 
negative value indicates proliferation of cells compared to the blank or carrier. Otherwise, 
the value could be expressed as proliferation (%) if the ODsample is higher than the ODblank. 
Inhibition (%) = 
(ODblank – ODsample) 
× 100 % 
(ODblank) 
Proliferation (%) = 
(ODsample –ODblank) 
× 100 % 
(ODblank) 
 
3.6.2 Antioxidant - Ferric reducing antioxidant power (FRAP) 
The FRAP assay utilizes the antioxidant present in the sample as a reductant to reduce 
oxidant present in the reagent through a redox-linked colorimetric assay. The assay has been 
reported to be well suited for biological fluids, such as plasma and plant extracts, to assess their 
“antioxidant” activity (Benzie & Strain, 1996). This redox reaction occurs at a low pH. The 
ferric tripyridyltriazine (TPTZ- Fe3+) complex is reduced to the ferrous form (TPTZ- Fe2+) by 
electron donating antioxidants; the reduced complex is detected spectrophotometrically at 593 
nm. Therefore, the reducing power of the sample may be referred as the total antioxidant power. 
The reaction is summarized as follows:- 
TPTZ-Fe3+ TPTZ-Fe
2+
Electron from antioxidants
low pH 593 nm
(Blue)  
The FRAP reagent was prepared by combining 300 mM acetate buffer, 10 mM TPTZ 
solution in 40 mM HCl and 20 mM FeCl3.6H2O, at a ratio of 10:1:1. FRAP reagent was 
incubated at 37 ºC prior to use. Ten μl of sample reconstituted in carrier (solvent or ultrapure 
water) was mixed with 300 μl of FRAP reagent and the mixture was incubated at 37 ºC for 4 
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minutes in the microplate reader. Absorbance of the complex was read at 593 nm. Sample 
readings were referenced to the standard curve of ferrous sulphate heptahydrate, 
FeSO4•7H2O. The FRAP value was expressed as mmol Fe
2+
/100g sample 
FRAP value 
= 
µM Fe
2+ 
 
(mmol Fe
2+
 / 100g sample) µg/ml sample  
 
= 
µmol/1000 ml Fe
2+ 
 
 µg/ml sample  
 
= 
mmol Fe
2+ 
× 100 
 100g sample 
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4.0 RESULTS AND DISCUSSION 
The present study is based upon, two Schiff base ligands which  can be prepared via 
the condensation reactions of N-(3-aminopropyl)morpholin with salicyclaldehyde (for L
1
H) 
or 5-chlorosalicylaldehyde (for L
2
H).  Both ligands were obtained as yellow oil and 
characterized by elemental analyses, IR, 
1
H-NMR, 
13
C-NMR, and electronic spectra (UV-
Vis). Although the ligands can be isolated and then used for the metal complexation, it was 
found more convenient to prepare them in situ. Treatment of the in situ prepared ligands 
with the appropriate divalent zinc, copper or nickel salts, in 1:1 or 2:1 ratio, led to the 
formation of the corresponding Schiff base metal complexes. The metal complexes have 
been characterized, both in the solid state and in solution, by a variety of techniques, 
including single-crystal X-ray diffraction analyses, IR, 
1
H NMR, 
13
C-NMR, and electronic 
spectra.  
The Schiff ligands and their complexes are soluble in most polar solvents such as 
ethanol, methanol, tetrahydrofuran (THF), and dimethyl sulfoxide (DMSO) but they are 
insoluble in non-polar solvent such as chloroform. 
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4.1 Characterizations of ligand, L
1
H and its metal complexes 
4.1.1 Elemental analyses 
 The analytical data of L
1
H, zinc, copper and nickel complexes are consistent with 
the proposed structures. Table 4.1 shows molecular formulae and microanalysis data of 
ligand, L
1
H and its complexes. 
Table 4.1: Analytical data of ligand, L
1
H and its complexes. 
Compound 
Molecular 
Formulae 
Elemental Compositions Percentage(%),  
C H N 
L
1
H C14H20N2O2 
66.79 7.79 10.77 
(67.71) (8.12) (11.28) 
[Zn(L
1
)2] C28H38N4O4Zn 
60.25 7.05 10.03 
(60.05) (6.84) (10.00) 
[Zn(L
1
)2Cl] C14H20N2O2Cl2Zn 
43.73 4.89 7.24 
(43.72) (5.24) (7.28) 
[Cu(L
1
)2] C28H38N4O4Cu 
60.25 7.05 10.03 
(60.25) (6.86) (10.04) 
[Ni(L
1
)2] C28H38N4O4Ni 
60.63 7.07 10.12 
(60.78) (6.92) (10.13) 
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4.1.2 IR Spectral Data 
The IR spectra of the free ligand and the complexes exhibit various bands in the 450-
4000 cm
-1
 region. Table 4.2 shows some important vibrational bands for the IR spectra of 
ligand L
1
H and its complexes. 
The infrared spectrum provides information of the elucidation of functional groups 
attached to the investigated compounds. The characteristic vibration frequencies of the 
complexes on comparison with the free ligands reveal remarkable changes. The mode of 
coordination of the ligands are observed by the absence of the free hydroxyl group (O-H) 
band, shifting of imine (C=N) and (C-O) phenolic signals and also the formation of new 
metal-oxygen (M-O) and metal-nitrogen (M-N) bands. As pointed out by Percy and 
Thornton (1973), the (M-O) and (M-N) at lower frequency assignments are at times very 
difficult due to the interference with the vibration bands of the ligand. 
IR spectrum of the free ligand shows a weak intensity broad band at frequency 3505 
cm
-1
 assigned to (O-H) stretching (Mikhaylova et. al., 2006). The broadness of the signal 
indicates the involvement of hydroxyl group in the intramolecular or intermolecular 
hydrogen bonding interaction (Denisov et. al., 1997).  The spectra exhibits very strong and 
sharp absorption band at 1630cm
-1
 attributed to the C=N stretching vibration (Gaballa et. al., 
2007). It was confirmed that the amino and carbonyl groups of the starting reagents have 
been converted into their corresponding Schiff base (Nakamoto, 1986; Leovoc et. al., 2005).  
Treatment of the in situ prepared ligands with the appropriate zinc, copper or nickel 
divalent salts, led to the formation of the corresponding Schiff base metal complexes. The 
complexation of the ligands is accompanied by shifts of IR ν(C=N) bands to lower or higher 
frequencies, implying the involvement of the azomethine N atoms in the coordination (Sang 
& Lin, 2010; El-Sonbati, 1991). This can be explained by donation of electrons from 
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nitrogen to empty d-orbitals of the metal ion (Aranha et, al., 2007). In addition, the 
withdrawal of electron density from the nitrogen atom owing to co-ordination (Mustafa et. 
al., 2009), indicate complexation with the metal center (Sarkar et. al., 2008; Cukurovali et. 
al., 2006; Yin et. al., 2005). 
Furthermore, the disappearance of a broad band, (O-H) vibration at around 3500 
cm
-1
 indicate the deprotonation of the phenolic oxygen and cleavage of the hydrogen bond 
with involvement of the oxygen atom in bonding. Hence, the stretching vibration of the 
phenolic C-O group bands in IR spectra of the complexes was shifted about 20-30 cm
-1
 to 
higher frequencies compared to ν(C-O) in ligand L1H (Martin et. al., 1986). This confirms 
the participation phenolic oxygens in coordination, subsequent to deprotonation. The 
appearance of new bands in the region 564-609 cm
-1
 and 456-470 cm
-1
 which are assigned to 
ν(M-O) and ν(M-N) respectively (Deshmukh et. al., 2010; Chandra et. al., 2006). These 
bands show evidence regarding the bonding of the metal ion with the nitrogen and oxygen 
atom of the Schiff base ligands.  
For the [Zn(L
1
)Cl2] complex, broad bands appeared at 3397 cm
-1
 attributable to N-H at the 
morpholine ring (Appendix A.2). 
 In summary, the IR study shows that the ligand L
1
H coordinates to metal ion via 
phenolic oxygen and imine nitrogen. 
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Table 4.2: Important IR data for L
1
H and metal complexes. 
Compound 
Wavenumber (cm
-1
) 
(O-H) / (N-H) (C=N) ar(C=C) (C-O)ph ar(C-H)bend  (M-O) (M-N) 
L
1
H 
3525 1630 1460 1279 759 
– – 
broad strong strong strong medium 
[Zn(L
1
)2] – 
1626 1463 1317 759 601 462 
strong medium medium medium weak weak 
[Zn(L
1
)Cl2] 
3397 1636 1445 1303 755 564 465 
broad strong strong strong strong medium weak 
[Cu(L
1
)2] – 
1613 1445 1330 760 609 456 
strong strong strong strong weak weak 
[Ni(L
1
)2] – 
1607 1447 1332 757 599 470 
strong strong strong strong medium medium 
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Figure 4.1: IR spectra for L
1
H.
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Figur
e 4.2: IR spectra for [Cu(L
1
)2]
   49 
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4.1.3 
1
H NMR Spectral Data 
The 
1
H NMR spectral data of L
1
H and its zinc(II) complexes were recorded in d6-
dimethylsulphoxide (DMSO-d6) solution using tetramethylsilane (TMS) as internal 
reference. The spectral data were summarized in Table 4.3 and the spectrum given in Figures 
4.3 and 4.4 respectively. 
The 
1
H NMR spectrum of the L
1
H ligand with four different proton environments 
were observed, phenol hydrogens, azomethine hydrogens, aromatic hydrogens and also the 
aliphatic hydrogens. 
1
H NMR data displays singlet signal at 13.65 ppm attributed to O-H 
proton of the phenolic group. Generally, the phenol proton was shifted downfield due to 
intramolecular hydrogen bonding (Bu et. al., 1997). The singlet characteristic peak at 8.55 
ppm was assigned to the imine HC=N hydrogen (Nelson et. al., 1981). The aromatic protons 
of the Schiff base ligand appear in the region 7.42-6.90 ppm with integration value 
corresponding to four protons. The aliphatic peaks resonate at the most shielded range from 
3.61-1.78 ppm. Based on the 
1
H NMR data and the proposed structure, the ligand L
1
H are 
successfully synthesized. 
The complexation of the ligand with 1:1 or 2:1 ligand/metal ratios shows significant 
changes in the 
1
H NMR spectra.  The phenol hydrogens signals in the L
1
H spectrum 
disappear in the spectrum of zinc(II) complexes, indicating the chelation of metal ion 
through phenolic oxygen upon deprotonation (Agarwala et. al., 1994). This is supported by 
upfield shifts of the imine HC=N signals in spectra of the zinc complexes when compared to 
those of the free ligands (Szlyk et. al., 2002). Whereas, for the [Zn(L
1
)2Cl] complex the 
imine HC=N peak shifted to lowfield at 10.26 ppm due to the coordination of the imine 
nitrogen lone pair to the metal ion(Syamal & Maurya, 1989; Selvakumar & Vancheesan, 
1995). This downfield shift is explained on the basis of the close proximity of the imine 
proton to the zinc(II) ion (Ustynyuk et. al., 1971).The data also shows that aromatic 
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hydrogens, underwent slight shifting to higher field, whereas the aliphatic protons remain 
unchanged. 
Briefly, loss of phenolic hydrogens and shifting of imine peaks demonstrated the 
divalent zinc ion chelate via nitrogen from azomethine and phenolic oxygen. Therefore, the 
L
1
H has probably functioned as a N,O-bidentate ligand.  
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Table 4.3: 
1
H-NMR spectral data of L
1
H and its zinc complexes. 
Compound 
Chemical Shift, δ(ppm) 
Proton Numbering Scheme 
OH
1
 H
2
C=N H Aromatic H Aliphatic 
L
1
H 13.65 8.55 7.42–6.90 3.61–1.78 
O
N N
1HO
HArH2
HAr
HAr
HAr  
[Zn(L
1
)2]  8.47 7.27–6.50 3.60–1.24 
[Zn(L
1
)2Cl2]  10.26 7.66-6.98 3.60-2.09 
 Chapter 4 | Results and Discussions          52 
 
           
 
Figure 4.3: 
1
H-NMR spectra for L
1
H.
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Figure 4.4: 
1
H-NMR spectra for [Zn(L
1
)2].
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4.1.4 
13
C-NMR Spectral Data 
The 
13
C-NMR spectral data of the Schiff base ligand (L
1
H) and its zinc(II) 
complexes were recorded in d6-dimethylsulphoxide (DMSO-d6) solution. The spectrums are 
given in Figure 4.5, 4.6 respectively and the spectral data are tabulated in Table 4.4.  
 The spectrum exhibits 12 signals attributed to 12 different types of carbon 
environment. The azomethine carbon HC=N resonates at 160.9 ppm and the aromatic 
carbons attached to the hydroxyl groups appear in the most downfield peak at 164.8 ppm. 
The analogous Schiff base carbon atoms bonded to the nitrogen is of the sp
2
 type which is 
expected to resonate at about 160 ppm (Bocâ et. al., 2000). The spectrum display downfield 
shifts of the ligand HC=N resonances upon complexation with Zn(II). Loss of phenolic 
hydrogen atoms in 
1
H NMR spectra and downfield shifts of C-O resonances in 
13
C NMR 
spectra of the zinc complexes, further suggest participation of the phenolate in metal 
coordination. The chemical shift in region 136-110 ppm clearly assigned to carbon at the 
aromatic rings. Besides, the aliphatic carbon indicated by the peaks at the range 66-25 ppm 
in spectra of the ligand and the zinc(II) complexes. 
 Nevertheless, the [Zn(L
1
)Cl2] complex shows upfield shifting of the imine HC=N 
due to the zinc(II) ions attached to two chlorides atoms. The chlorides atom have high 
electron density, thus it increases the shielding effect of the carbon atom (Ning, 2011).  
 In summary, these results implied that ligand L
1
H coordinated to zinc ions through 
the phenol oxygen and azomethine nitrogen, which has also been concluded from IR and 
1
H 
NMR spectral studies. 
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Table 4.4: 
13
C-NMR spectral data of L
1
H and its zinc complexes. 
Compound 
Chemical Shift, δ(ppm) 
Carbon Numbering Scheme 
C–OH  HC1=N H Aromatic H Aliphatic 
L
1
H 165.84 160.91 132.2–116.5 66.1–27.1 
O
N N
C 1
C
Ar
C
C
C
C
C
HO
H H
Ar
HAr
H
Ar
H
Ar
 
[Zn(L
1
)2]  167.77 135.9–113.9 66.0–26.7 
[Zn(L
1
)2Cl]  136.39 129.27-117.19 65.99-23.37 
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Figure 4.5: 
13
C-NMR spectra for L
1
H.
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Figure 4.6: 
13
C-NMR spectra for [Zn(L
1
)2].
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4.1.5 UV-Vis spectra 
The electronic absorption of the L1H and its divalent Cu(II) and Ni(II) chelates 
have been recorded in THF and their corresponding data are  listed in Table 4.5. 
The Schiff base ligand electronic spectra shows an intense bands at 255 ppm 
attributed to intraligand π→π* transition of the aromatic ring. The absorption at 316 ppm 
assigned to n→π* transition involving molecular orbitals of C=N chromophore (Tas et. al., 
2010). These absorptions also appear in the spectra of the complexes with different energy 
and intensity which most likely originates from the metalation. Hence, these increases the 
conjugation and delocalization of the whole electronic system resulting in the energy 
change of π→π* and n→π* transitions (Kalanithia et. al., 2012). 
The spectrum of Cu(II) complex exhibit π→π* and  n→π* transitions bands at the 
higher energy due to hypsochromic shift, confirming the complexation (Lu et. al., 2000). 
The presence of new absorption band at 307 nm assignable to the charge transfer transition 
of the ligand to metal (LMCT) between the lone pair of phenolate oxygen donor and the 
Cu(II) ions. This further confirms the coordination of ligand toward the metal ions (Vanco 
et. al., 2008). Moreover, the complex spectrum displays bands at 364 nm and 619 nm. This 
band corresponds to d-d transitions which are attributed to 
2
B1g→
2
Eg and 
2
B1g→
2
B2g 
transitions respectively. Therefore, these indicate the possibility of the square planar 
geometry for this complex (Chandra et. al., 2009). 
In the Ni(II) complex spectra, the intense absorptions assigned to π→π* and  n→π* 
transitions bands shifted to the higher energy (red shift) upon complexation (Lu et. al., 
2000).The LMCT transition appears at 326 ppm indicates the chelation within the lone pair 
of phenolate oxygen donor and the metal ions (Vanco et. al., 2008).
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Spectrum of the nickel complex shows an absorption band at 614 nm, assignable to 
a 
1
A1g→
1
A2g transition and a shoulder band at 413 nm attributed to the 
1
A1g→
1
B1g 
transition in the Molecular Orbital. Thus, these suggest the nickel complex exhibit a square 
planar stereochemistry (Singh et. al., 2007).  
In summary from the electronic spectra, the charge transfer and the d-d transition in 
complexes have provides evidence suggesting that the complexes form four-coordinate. 
The Cu(II) and Ni(II) complexes are most likely a square planar geometry (Chandra et. al., 
2009; Singh et. al., 2007).  
Table 4.5: UV-Visible spectral data for L
1
H and its complexes.  
Compound 
λ max λ max ε max 
Assignment 
(nm) (cm
-1
) (mol
-1
dm
3
cm
-1
) 
L
1
H 255 39216 11794 π→π* 
 316 31646 4568 n→π* 
[Cu(L
1
)2] 245 40816 37185 π→π* 
 296 33784 7363 n→π* 
 307 32573 10158 LMCT 
 364 27473 11836 d-d transition 
2
B1g→
2
Eg 
 619 16155 112 d-d transition 
2
B1g→
2
B2g 
[Ni(L
1
)2] 245 40816 19703 π→π* 
 266 37594 13028 n→π* 
 326 30675 3312 LMCT 
 413 24213 1751 d-d transition 
1
A1g→
1
B1g 
 614 16287 75 d-d transition 
1
A1g→
1
A2g 
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Figure 4.7: UV-Vis spectra for L
1
H. 
 
 
Figure 4.8: UV-Vis spectra for [Ni(L
1
)2]. 
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4.1.6 X-ray Crystallographic Data Collection 
The complexes of L
1
 crystal data and refinement are summarized in Table 4.6. 
4.1.6.1 Crystal structure of [Zn(L
1
)2] 
 
Scheme 4.1: Synthesis of [Zn(L
1
)2]. 
Crystals of [Zn(L
1
)2] were obtained through the reaction of L
1
H with zinc(II) 
acetate in a 2 : 1 ratio (scheme 4.1). As depicted in figure 4.9, the deprotonated Schiff 
base, L
1
, chelates Zn(II) via phenolate oxygen and imine nitrogen. The metal is on a 
crystallographic two-fold rotational axis of symmetry and is four-coordinate by two mono-
anionic ligands to form two six-membered chelating rings. The dihedral angle between the 
two rings is 79.61(7)˚ and the coordination geometry can be best described as a distorted 
tetrahedron. Table 4.7 lists selected bond lengths and angles for the structure. The Zn–O 
and Zn–N distances of 1.9221(14) and 1.9916(16) Å are comparable with values reported 
for similar structures (Torzilli et. al., 2002; Schon et. al., 2004; Pastor et. al., 2011). 
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Figure 4.9: The crystal structure and atom-labeling scheme of [Zn(L
1
)2] (50% probability 
ellipsoids). The two-fold rotation axis is perpendicular to the plane of the paper. 
4.1.6.2 Crystal structure of [Zn(L
1
)Cl2] 
 
Scheme 4.2: Synthesis of [Zn(L
1
)Cl2]. 
The [Zn(L
1
)Cl2] complex was obtained via the complexation of ZnCl2 with the in 
situ prepared Schiff base. The Schiff base ligand coordinates the metal ion via its phenolate 
oxygen and imine nitrogen atoms. The morpholine ring N atom stays away from the 
coordination and is protonated, implying the zwitterionic nature of the molecule. The 
tetrahedral geometry around the zinc(II) ion is completed by two Cl atoms. The 
coordination bond lengths in the complex are comparable to the corresponding values in 
similar structures (Qui, 2006; Ye & You, 2008; Zhu, 2008). In the crystal, N—H···O 
hydrogen bonding connects pairs of the molecules into centrosymmetric dimers. The 
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dimers are linked through C—H···O, C—H···Cl and C—H···π interactions into a three-
dimensional network. 
 
Figure 4.10: The crystal structure and atom-labeling scheme of [Zn(L
1
)Cl2] (50% 
probability ellipsoids). Hydrogen atoms are drawn as spheres of arbitrary radius. 
4.1.6.3 Crystal structure of [Cu(L
1
)2] 
 
Scheme 4.3: Synthesis of [Cu(L
1
)2]. 
The reaction of L
1
H with copper(II) acetate in a 2 : 1 ratio led to the formation of 
[Cu(L
1
)2] (scheme 4.3). As shown in Figure 4.11, the copperis placed on a centre of 
inversion and is four-coordinate by two deprotonated Schiff bases, L
1
, in a square- planar 
environment. The ligand uses phenolate oxygen and imine nitrogen to chelate. The 
morpholine ring adopts a chair conformation and its nitrogen and oxygen atoms stay away 
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from coordination. Deviations from ideal square-planar geometry are reflected in the O1–
Cu1–N1 bite angle of 91.50(5)°. For four-coordinate Cu(II) complexes, bis-chelated by 
salicylaldimine ligands, both tetrahedral (Dhar et. al., 2003; Fernandez et. al., 2010) and 
square-planar (Chen et. al., 2005; You & Chi, 2006) geometries have been observed. There 
is an example wherein the unit cell of the structure of a salicylaldimine Cu(II) complex 
contains both square-planar and flattened tetrahedral structures (Polishchuk et. al., 1986). 
 
Figure 4.11: The crystal structure and atom-labeling scheme of [Cu(L
1
)2] (50% 
probability ellipsoids). 
4.1.6.4 Crystal structure of [Ni(L
1
)2] 
Scheme 4.4: Synthesis of [Ni(L
1
)2].
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The crystal structure is represented in Figure 4.12 and selected bond lengths and 
angles are given in Table 4.7. The nickel, located on a centre of is four-coordinate in a 
distorted square plane geometry defined by two N,O-bidentate mono-anionic L
1
. 
 
Figure 4.12: The crystal structure and atom-labelling scheme of [Ni(L
1
)2] (50% 
probability ellipsoids). 
 
 
Figure 4.13: The crystal packing structure [Ni(L
1
)2]  along b-axis.
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Table 4.6: Crystal data and refinement parameters for L
1
 complexes. 
 [Zn(L
1
)2] [Zn(L
1
)Cl2] [Cu(L
1
)2] [Ni(L
1
)2] 
Empirical formula   
Crystal system   
Space group   
Unit cell dimensions  
a (Å)                                                                              
b (Å)                                                                              
c (Å)                                                                            
β (°)                                                                              
Volume (Å
3
)  
Z  
Density (calculated) (g cm
-3
) 
Crystal size (mm
3
)  
θ range for data collection  (°)  
Reflections collected  
Independent reflections  
Completeness    
Data / restraints / parameters  
Goodness-of-fit on F
2
  
Final R indices [I >2σ (I)]  
R indices (all data)  
C28 H38 N4 O4 Zn 
Orthorhombic 
F d d 2 
 
19.7143(12)
 48.358(3)
5.5790(4) 
5318.7(6) 
8 
1.399  
0.26 x 0.11 x 0.05  
2.23 to 26.76 
11709  
2816 [Rint = 0.0407] 
To θ = 26.77° : 99.9 %  
2816 / 1 / 168 
1.040 
R1 = 0.0268, wR2 = 0.0579 
R1 = 0.0303, wR2 = 0.0592 
C14 H20 Cl2 N2 O2 Zn 
Monoclinic 
P 21/c 
 
8.11276 (10)  
11.21021 (13)  
18.4097 (2)  
92.0168 (6) 
1673.24 (4) 
4 
1.527 
0.37 × 0.32 × 0.25 
2.2 to 30.4 
9373  
3557 [Rint = 0.017] 
To θ = 26.77° : 99.9 %  
2824 / 1 / 193 
1.070 
R1 = 0.0200, wR2 = 0.0510 
 
C28 H38 Cu N4 O4 
Monoclinic 
P 21/n 
 
9.6854(3)  
7.9100(3) 
17.6325(2) 
90.067(3) 
1350.85(3) 
2 
1.372  
0.26 x 0.19 x 0.11  
2.31 to 27.00 
9091 
2932 [Rint = 0.0262] 
To θ = 27.50° : 99.4 % 
2932 / 0 / 169 
1.035 
R1 = 0.0304, wR2= 0.0757 
R1 = 0.0367, wR2= 0.0787 
C28 H38 N4 Ni O4 
Monoclinic 
P 21/n 
 
9.7050(2)  
7.9293(2) 
19.9434(4) 
119.1190(10) 
1340.75(5)  
2 
1.371  
0.21 x 0.13 x 0.09  
2.34 to 24.99 
2358 
2358 [Rint = 0.0000] 
To θ = 24.99° : 99.9 % 
2358 / 0 / 170 
1.040 
R1 = 0.0280, wR2= 0.0673 
R1 = 0.0301, wR2= 0.0690 
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Table 4.7: Selected bond lengths (Å) and bond angles (°) for L
1
 complexes. 
[Zn(L
1
)2] [Zn(L
1
)Cl2] [Cu(L
1
)2] [Ni(L
1
)2] 
Bond lengths 
Zn(1)-O(1)                        1.9221(14) 
Zn(1)-N(1)                        1.9916(16) 
O(1)-C(1)                          1.319(2) 
N(1)-C(7)                          1.285(2) 
 
 
 
Bond angles 
O(1)-Zn(1)-O(1)#1            113.70(9) 
O(1)-Zn(1)-N(1)                96.18(6) 
O(1)-Zn(1)-N(1)#1            120.66(6) 
N(1)-Zn(1)-N(1)#1            111.23(9) 
 
Zn(1)-O(1)                        1.9644 (9) 
Zn(1)-N(1)                        2.0049 (11) 
Zn(1)-Cl(1)                        2.2206 (3) 
Zn(1)-Cl(2)                        2.2570 (3) 
O(1)-C(1)                           1.3254(15) 
N(1)-C(7)                           1.2825(17) 
 
 
O(1)-Zn(1)-N(1)                 95.72(4) 
O(1)-Zn(1)-Cl(1)                112.95(3) 
O(1)-Zn(1)-Cl(2)                105.87(3) 
N(1)-Zn(1)-Cl(1)                112.96(3) 
N(1)-Zn(1)-Cl(2)                112.88(3) 
Cl(1)-Zn(1)-Cl(2)               112.363(13) 
 
 
Cu(1)-O(1)                       1.8908(12) 
Cu(1)-N(1)                       2.0029(14) 
O(1)-C(1)                         1.308(2) 
N(1)-C(7)                         1.294(2) 
 
 
 
 
O(1)#2-Cu(1)-O(1)            180.0 
O(1)-Cu(1)-N(1)#2            88.50(5) 
O(1)-Cu(1)-N(1)                91.50(5) 
N(1)#2-Cu(1)-N(1)            180.0 
 
Ni(1)-O(1)                        1.8355(17) 
Ni(1)-N(1)                        1.9214(19) 
O(1)-C(1)                         1.299(3) 
N(1)-C(7)                         1.292(3) 
 
 
 
 
O(1)-Ni(1)-O(1)#1            180.00(5) 
O(1)-Ni(1)-N(1)                92.63(8) 
O(1)-Ni(1)-N(1)#1            87.37(8) 
N(1)-Ni(1)-N(1)#1            180.0 
Symmetry transformations used to generate equivalent atoms: #1 -x+1,-y+2, z; #2 -x+1,-y+2,-z        
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4.2 Characterizations of ligand, L
2
H and its metal complexes 
4.2.1 Elemental analyses 
 Table 4.8 shows molecular formulae and the analytical data of ligand L
2
H, zinc, 
copper and nickel complexes. The microanalysis data are in a good agreement with the 
proposed formulations. Based on elemental compositions values, some of the complexes 
have molecule of water and methanol are found outside the coordination sphere. 
Table 4.8: Analytical data of ligand, L
2
H and  its complexes. 
Compound 
Molecular 
Formulae 
Elemental Compositions Percentage (%),  
C H N 
L
2
H C14H19N2O2Cl 
60.63 7.07 10.12 
(59.47) (6.77) (9.91) 
[Zn(L
2
)2]·3H2O C28H42N4O7Cl2Zn 
49.24 6.19 8.20 
(49.24) (6.20) (8.20) 
[Zn(L
2
)(OAc)] C16H21N2O4ClZn 
47.43 5.05 6.85 
(47.31) (5.21) (6.90) 
[Cu(L
2
)2] C28H36N4O4Cl2Cu 
53.56 5.82 8.91 
(53.63) (5.79) (8.93) 
[Cu(L
2
)Cl]·CH3OH C15H22Cl2CuN2O3 
43.30 4.69 7.23 
(43.64) (5.37) (6.79) 
[Ni(L
2
)2] C28H36N4O4Cl2Ni 
53.96 5.82 8.91 
(54.05) (5.83) (9.00) 
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4.2.2 IR Spectral Data 
The important feature of solid IR spectra of ligand, L
2
H and its Zn(II), Cu(II) and 
Ni(II) complexes are summarized in Table 4.9. 
The coordination of the ligand to the metal centre is based by comparing the IR 
spectra of the Schiff base complexes with the free ligand. The vibrational bands of the 
complexes are similar to the ligand and additional of two new bands correspond to the 
formation of the metal-ligand bond. The interference of signals of the free ligand, 
complicates the assignment of the (M-O) and (M-N) bands (Percy & Thornton, 1973). 
The synthesized Schiff base ligand which gave oily products exhibits a strong 
intensity absorption band of the azomethine (C=N) groups at 1636 cm
-1
 that formed via 
condensation of morpholine and chlorosalicyclaldehyde (Gaballa et. al., 2007). In addition, 
a frequency band at 3384 cm
-1
 which is attributed to (O-H) stretching from 
chlorosalicyclaldehyde (Mikhaylova et. al., 2006), further indicates the absence of the 
amino group from the morpholine. 
Treatment of the ligands with the corresponding metal salts, accompanied by 
deprotonation upon complexation, led to the coordination of the metal ion through the 
oxygen atom of the chlorosalicylaldehyde hydroxyl group. The deprotonation of the 
phenolic group is confirmed by the disappearance of the phenolic O-H stretching bands in 
the spectrum of the complexes. Furthermore, stretching vibration of the phenolic (C-O) 
groups occur at higher frequencies as compared to L
2
H spectra. The shifting to the higher 
energy suggested the chelation of metal(II) ions to phenolic oxygen atom (Tamizh et. al., 
2009). Another evidence shows the participation of (C=N) group in the coordination site is 
attributable to the shifting of (C=N) bands to the lower or higher frequencies. The 
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changes in this vibrational frequencies shows that the imine nitrogen atom has coordinated 
to the metal(II) ions (Golcu et. al., 2005). 
Further conclusive idea of the complexation was shown by the presence of two new 
bands at the lower frequencies range of 549-562 and 461-478 which are assigned to (M-
O) and (M-N) respectively. These newly bands, further indicated the chelation of the 
metal ion to the ligand via phenolic oxygen and azomethine nitrogen atom. 
For the [Zn(L
2
)2]•3H2O and [Cu(L
2)Cl]•CH3OH complexes,  strong bands appeared 
at 3340 and 3440cm
-1
 respectively that can be assigned to the (OH) modes of coordinated 
and lattice water or methanol, present in the complexes (Nakamoto, 1986; Leovoc et. al., 
2005). 
In conclusion, the IR study shows that the ligand L
2
H coordinates to metal ion via 
phenolic oxygen and imine nitrogen. 
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Table 4.9: Important IR data for L
2
H and  metal complexes. 
Compound 
Wavenumber (cm
-1
) 
(O-H) (C=N) ar(C=C) (C-O) ar(C-H)bend (C-Cl)  (M-O) (M-N) 
L
2
H 
3384 1636 1483 1279 822 697 
– – 
weak strong strong strong medium medium 
[Zn(L
2
)2]·3H2O 
3340 1618 1461 1296 832 716 552 476 
broad strong strong strong medium strong weak weak 
[Zn(L
2
)(OAc)] – 
1646 1461 1314 850 703 559 470 
strong strong strong strong strong medium medium 
[Cu(L
2
)2] – 
1624 1455 1312 834 720 560 478 
strong strong medium strong strong medium weak 
[Cu(L
2
)Cl]·CH3OH 
3440 1625 1460 1316 850 703 562 470 
medium strong medium medium medium strong weak weak 
[Ni(L
2
)2] – 
1614 1461 1323 822 731 549 461 
strong strong medium strong strong weak weak 
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Figur
e 4.14: IR spectra for L
2
H.
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ure 4.15: IR spectra for [Ni(L
2
)2].
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4.2.3 
1
H NMR Spectral Data 
The 
1
H NMR spectral data of L
2
H and its zinc(II) complexes were recorded in d6-
dimethylsulphoxide (DMSO-d6) solution. The spectrum data were illustrated in Table 4.10 
and in Figures 4.16 and 4.17 respectively. 
The spectrum of ligand L
2
H exhibits two singlet signals at 13.75 and 8.53 ppm 
attributed to the hydrogen of the phenol groups and imine HC=N protons (Nelson et. al., 
1981) respectively. The intramolecular hydrogen bonding effect causes the phenol 
hydrogen peak to appear at the most downfield region (Bu et. al., 1997). The aromatic 
protons of Schiff base ligand resonate at the range 7.53-6.88 ppm with integration 
corresponding to three protons. Nevertheless, the fourteen hydrogens from the aliphatic 
side were observed at the upfield region 3.62–1.78 ppm. The L2H ligands are successfully 
synthesized and correspond to the structural predicated. 
 The comparison between the 
1
H NMR of the ligand and its zinc(II) complexes 
shows that zinc ion chelate through phenol oxygen and imine nitrogen. The spectrum 
disappearance of the most deshielded peak indicates deprotonation of the phenolic oxygen, 
upon complexation (Agarwala et. al., 1994). Further supported by negative shifts of the 
imine HC=N protons illustrated in the spectrum of zinc(II) complexes as compared to the 
ligand (Szlyk et. al., 2002). This shift provides evidence of the coordination of the imine 
nitrogen lone pair to the metal ions. Whereas, the chemical shift of the aromatic and 
aliphatic protons remain unaffected. 
 In summary, the zinc(II) complexes were successfully synthesized but the 
coordination modes have to be further investigated. 
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Table 4.10: 
1
H-NMR spectral data of L
2
H and its zinc complexes. 
Compound 
Chemical Shift, δ(ppm) 
Proton Numbering Scheme 
OH
1
 H
2
C=N H Aromatic H Aliphatic 
L
2
H 13.75 8.53 7.53–6.88 3.62–1.78 
O
N N
1HO
HArH2
Cl
HAr
HAr  
[Zn(L
2
)2]·3H2O  8.47 7.53–6.66 2.33–1.24 
[Zn(L
2
)(OAc)]  8.29 7.25–6.63 3.66–1.22 
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Figure 4.16: 
1
H-NMR spectra for L
2
H. 
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Figure 4.17: 
1
H-NMR spectra for [Zn(L
2
)2]•3H2O.
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4.2.4 
13
C NMR spectra  
The spectral data of ligand L
2
H and its zinc(II) complexes are summarized in Table 
4.11 and the spectra are given in Figures 4.18, 4.19 respectively. 
 The 
13
C NMR spectrum of the ligand displays 12 peaks which corresponding to 12 
types of carbon. The most deshielded signal was assigned to phenolic hydroxyl carbon at 
164.77 ppm due to the electronegative effect of the oxygen attached to the carbon. While, 
slightly lower chemical shift at 160.28 ppm are assigned to azomethine carbon (Bocâ et. 
al., 2000). Furthermore, for the complexes, the azomethine carbon peaks was shifted 
downfield. This led to participation of the nitrogen atom in the chelation. The shifts of C-O 
resonances further confirmed involvement of the phenolate group via complexation as 
shown in Figure 4.19. The chemical shift in region 134-116 ppm attributed to five carbon 
at the aromatic rings and the peak exhibits at the range 65-22 ppm represents the aliphatic 
carbons in spectra of the L
2
H ligand and the zinc(II) complexes. 
 Therefore, these results indicate that ligand L
2
H coordinated to zinc ions through 
phenolate oxygen and azomethine nitrogen, which has been inferred from IR and 
1
H NMR 
spectral studies. 
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Table 4.11: 
13
C-NMR spectral data of L
2
H and its zinc complexes. 
Compound 
Chemical Shift, δ(ppm) 
Carbon Numbering Scheme 
C–OH  HC=N H Aromatic H Aliphatic 
L
2
H 164.77 160.28 131.9–118.8 66.1–26.9 
O
N N
C 1
C
Ar
C
C
C
C
C
HO
H H
Ar
ClAr
H
Ar
H
Ar
 
[Zn(L
2
)2]·3H2O  168.44 134.0–116.6 66.0–26.7 
[Zn(L
2
)(OAc)]  168.38 133.7–116.2 65.1–21.7 
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Figure 4.18: 
13
C-NMR spectra for L
2
H.
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Figure 4.19: 
13
C-NMR spectra for [Zn(L
2
)2].
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4.2.5 UV-Vis spectra 
The ligand electronic spectra displays two bands at 254 and 327 ppm assignable to 
intraligand π→π* transition of the aromatic ring n→π* transition of C=N chromophore 
repectively (Tas et. al., 2010). Upon complexation, the π→π* and  n→π* transitions bands 
shifted to higher energy due to hypsochromic shift (Lu et. al., 2000). The increased in the 
conjugation and delocalization of the whole electronic system, led to the energy change of 
π→π* and n→π* transitions (Kalanithia et. al., 2012). Additionally, the spectra of the 
complexes show absorptions peaks at the region 306-354 ppm attributed to ligand metal 
charge transfer (LMCT). The charge transfers are between the lone pair of phenolic 
oxygen donor and the divalent ions (Vanco et. al., 2008).  
The spectra of [Cu(L
2
)2] exhibits two new bands corresponding to d-d transitions. 
The shoulder band at 567 nm assigned to 
2
B1g→
2
B2g transition and the absorption at 374 
nm was attributed to 
2
B1g→
2
Eg transition. Hence, these suggest the complex demonstrate a 
square planar stereochemistry (Chandra et. al., 2009). 
The UV spectrum of the [Cu(L
2)Cl]• CH3OH complex show the absorption bands 
at 772 nm, 559 nm and 378 nm attributed to 
2
B1g→
2
A1g, 
2
B1g→
2
B2g and 
2
B1g→
2
Eg 
transitions respectively (Geeta et. al., 2010). It indicates the square planar geometry for 
this Cu(II) complex. 
Furthermore, in the nickel complex spectrum appears a low intensity broad band at 
619 nm which is attributed to 
1
A1g→
1
A2g transition of d-d orbital. Another band appears at 
415 nm corresponding to the 
1
A1g→
1
B1g transition. These transitions suggest the square 
planar geometry (Singh et. al., 2007). 
 
Chapter 4 | Results and Discussions 
       
  83 
          
In summary, the charge transfer and the d-d transition in complexes provides 
significant evidence proposing that the complexes form four-coordinate. The Cu(II) and 
Ni(II) complexes are expected to be a square planar geometry (Chandra et. al., 2009; Singh 
et. al., 2007; Geeta et. al., 2010). The coordination modes of the complexes will be further 
deliberate in X-ray crystallographic analysis. 
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Table 4.12: UV-Visible spectral data for L
2
H and its complexes.  
Compound 
λ max λ max ε max 
Assignment 
(nm) (cm
-1
) (mol
-1
dm
3
cm
-1
) 
L
2
H 254 39370 8907 π→π* 
 327 30581 4273 n→π* 
[Cu(L
2
)2] 246 40650 38735 π→π* 
 296 33784 8373 n→π* 
 306 32680 9157 LMCT 
 374 26738 9819 d-d transition 
2
B1g→
2
Eg 
 597 16750 116 d-d transition 
2
B1g→
2
B2g 
[Cu(L
2
)Cl]• CH3OH 247 40486 22413 π→π* 
 296 33784 4932 n→π* 
 354 28249 6165 LMCT 
 378 26455 5768 d-d transition 
2
B1g→
2
Eg 
 559 17889 265 d-d transition 
2
B1g→
2
B2g 
 772 12953 117 d-d transition 
2
B1g→
2
A1g 
[Ni(L
2
)2] 257 38911 18190 π→π* 
 290 34483 10191 n→π* 
 327 30581 9164 LMCT 
 415 24096 4897 d-d transition 
1
A1g→
1
B1g 
 619 16155 79 d-d transition 
1
A1g→
1
A2g 
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Figure 4.20: UV-Vis spectra for L
2
H. 
 
 
 
Figure 4.21: UV-Vis spectra for [Cu (L
2
)Cl]•CH3OH. 
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4.2.6 X-ray Crystallographic Data Collection 
The complexes of L
2
 crystal data and refinement are summarized in Table 4.13. 
4.2.6.1 Crystal structure of [Zn(L
2
)2] •3H2O 
 
Scheme 4.5: Synthesis of [Zn(L
2
)2]•3H2O. 
The complex was obtained via reaction of L
2
H with zinc(II) acetate in a 2 : 1 ratio 
(scheme 4.5). The asymmetric unit of the crystal structure contains one metal complex 
molecule, co-crystallized with three molecules of water. Figure 4.22 shows the molecular 
structure of the metal complex. Zn, located in a general position, is four-coordinated by 
two deprotonated L
2
 ligands through their phenolate O and azomethine N. The geometry of 
the coordination sphere can be described as a distorted tetrahedron from the dihedral angle 
of 86.80(7)° formed between the two six-membered chelating rings. Dissimilar to the 
structure of [Zn(L
1
)2], the three methylene groups of the spacer in each L
2
 adopt an all-
trans conformation. Selected bond lengths and angles for the structure are given in table 
4.14. The geometrical parameters pertaining to the coordination spheres are within normal 
ranges (Torzilli et. al., 2002; Schon et. al., 2004; Pastor et. al., 2011). 
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Figure 4.22: The crystal structure of [Zn(L
2
)2]•3H2O with 30% thermal ellipsoids. 
Water molecules and hydrogen atoms have been omitted for clarity. 
4.2.6.2 Crystal structure of [Zn(L
2
)(OAc)] 
 
Scheme 4.6: Synthesis of [Zn(L
2
)(OAc)]. 
The reaction of L
2
H with Zn(OAc)2 in a 1 : 1 ratio gave [Zn(L
2
)(OAc)] (scheme 
4.6). The asymmetric unit of the crystal structure consists of two crystallographically 
independent molecules with slightly different geometries. The weighted root mean square 
(rms) fit for the superposition of the non-H atoms in both molecules is 0.0412Å. Figure 
4.23 displays the molecular structure of one molecule. In contrast with the former 
structures, in this complex, the deprotonated Schiff base, L
2
, coordinates through not only 
the phenolate O and imine N, but also its morpholine nitrogen. Each ligand forms two six-
membered chelate rings with zinc, one of which (Zn1/O1/C1/C6/C7/N1) is planar whereas 
the other (Zn1/N1/C8/C9/C10/N2) adopts a chair conformation. The zinc is five-coordinate 
by tridentate L
2
 and a bidentate acetate. The coordination geometry is distorted square-
pyramidal as determined by Addison index of 0.11 (Addison et. al., 1984). Table 4.14 
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provides selected bond lengths and angles for [Zn(L
2
)(OAc)]. The Zn–Ophenolate distance 
of 1.9392(18)Å is within the normal range as are the Zn–N distances of 2.005(2) and 
2.140(2)Å (Tai et. al., 2008; Li & Huaxue, 2007). 
 
Figure 4.23: The molecular structure of [Zn(L
2
)(OAc)] with 40% thermal ellipsoids. 
Hydrogen atoms have been omitted for clarity. 
4.2.6.3 Crystal structure of [Cu(L
2
)2] 
 
Scheme 4.7: Synthesis of [Cu(L
2
)2]. 
Reaction of Cu(II) with two equivalents of H
2
L generated [Cu(L
2
)2] (scheme 4.7). 
The crystal structure is represented in figure 4.24 and selected bond lengths and angles are 
given in table 4.14. The copper, located on a centre of inversion, is four-coordinate in a 
distorted square plane defined by two N,O-bidentate mono-anionic L
2
. Distortion from 
ideal geometry is evident from cisoid-angles of 87.44(10)° and 92.56(10)°. The 
morpholine nitrogen and oxygen are not involved in coordination. The coordination 
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geometrical parameters are comparable to values observed in similar structures (Dhar et. 
al., 2003; Fernandez et. al., 2010). 
 
Figure 4.24: The crystal structure and atom-labeling scheme of [Cu(L
2
)2] 
(50% probability ellipsoids). 
4.2.6.4 Crystal structure of [Cu(L
2)Cl]•CH3OH 
Scheme 4.8: Synthesis of [Cu(L
2
)Cl] •CH3OH. 
The complex was obtained through reaction of H
2
L with an equimolar amount of 
copper(II) chloride (scheme 4.8). The crystal structure contains one methanol co-
crystallized with each Cu(II) complex. Figure 2.25 demonstrates the molecular structure of 
the copper(II) complex. Similar to the structure of [Zn(L
2
)(OAc)], the morpholine nitrogen 
of the deprotonated Schiff base, L
2
, is involved in metal coordination. Thus, the ligand is a 
mono-anionic N,N,Otridentate chelate to form one planar and one chair-like six- 
membered ring with copper.The four-coordinate copper is completed by Cl
-
. The rms 
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deviation from the least squares plane involving Cu1/Cl2/O1/N1/N2 is 0.0182(4) Å and 
copper atom is 0.0228(5) Å out of the coordination plane, Cl2/O1/N1/N2. Table 4.14 
gathers selected bond lengths and angles for [Cu(L
2)Cl]•CH3OH. The coordination 
geometrical parameters are in agreement with the values observed in similar structures 
(Latour  et. al., 1989; Shnulin et. al., 1977; Hisham et. al., 2009). 
 
 
Figure 4.25: The crystal structure of [Cu(L
2)Cl]•CH3OH with 40% thermal ellipsoids. 
The methanol and hydrogen atoms have been omitted for clarity. 
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Table 4.13: Crystal data and refinement parameters for L
2
 complexes. 
 [Zn(L
2
)2].3H2O [Zn(L
2
)(OAc)]  [Cu(L
2
)2] [Cu(L
2
)Cl].CH3OH 
Empirical formula   
Crystal system   
Space group   
Unit cell dimensions  
a (Å)                                                                              
b (Å)                                                                              
c (Å)                                                                            
α (°)                                                                              
β (°)                                                                              
γ (°)                                                                               
Volume (Å
3
)  
Z  
Density (calculated) (g cm
-3
) 
Crystal size (mm
3
)  
θ range for data collection  (°)  
Reflections collected  
Independent reflections  
Completeness    
Data / restraints / parameters  
Goodness-of-fit on F
2
  
Final R indices [I>2σ (I)]  
R indices (all data)  
C28 H42 Cl2 N4 O7 Zn 
Monoclinic 
P 21/c 
 
14.6066(14) 
11.7494(11) 
18.4867(18)  
101.488(3)
 
3109.1(5)  
4 
1.459  
0.31 x 0.19 x 0.06  
2.07 to 27.00 
16987 
6729 [Rint = 0.0357] 
To θ = 27.00° : 99.4 %  
6729 / 6 / 397 
1.033 
R1 = 0.0344, wR2 = 0.0728 
R1 = 0.0493, wR2 = 0.0781 
C16 H21 Cl N2 O4 Zn 
Orthorhombic 
P c a 21 
 
13.0216(2) 
10.2210(2) 
25.8385(4) 
 
 
 
3438.94(10) 
8 
1.569  
0.32 x 0.22 x 0.20 
1.99 to 27.00 
29957 
7401 [Rint = 0.0352] 
To θ = 27.00° : 100.0 %  
7401 / 1 / 435 
1.048 
R1 = 0.0254, wR2 = 0.0574 
R1 = 0.0300, wR2 = 0.0592 
C28 H36 Cl2 Cu N4 O4 
Triclinic 
P -1 
 
6.4917(14)  
8.5461(18)   
13.199(3)   
88.348(3) 
81.750(4) 
70.792(3) 
684.2(3) 
1 
1.522  
0.18 x 0.13 x 0.12  
2.52 to 25.48 
4784 
2511 [Rint = 0.0758] 
To θ = 25.48° : 98.7 %  
2511 / 0 / 178 
1.055 
R1 = 0.0574, wR2 = 0.1497 
R1 = 0.0649, wR2 = 0.1591 
C15 H22 Cl2 Cu N2 O3 
Monoclinic 
P 21/c 
 
8.8556(3)  
13.8205(2)  
14.0612(2)  
 
99.964(3) 
 
1694.98(4) 
4 
1.618 
0.51 x 0.41 x 0.30  
2.08 to 27.50 
12966 
3894 [Rint = 0.0179] 
To θ = 27.50° : 99.9 % 
3894 / 1 / 212 
1.041 
R1 = 0.0212, wR2 = 0.0533 
R1 = 0.0235, wR2 = 0.0543 
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Table 4.14: Selected bond lengths (Å) and bond angles (°) for L
2
 complexes. 
[Zn(L
2
)2].3H2O [Zn(L
2
)(OAc)]  [Cu(L
2
)2] [Cu(L
2
)Cl].CH3OH 
Bond lengths 
Zn(1)-O(1) 1.9122(15) 
Zn(1)-O(3) 1.9277(14) 
Zn(1)-N(3) 2.0116(17) 
Zn(1)-N(1) 2.0164(17) 
O(1)-C(1) 1.315(2) 
O(3)-C(15) 1.323(2) 
N(1)-C(7) 1.287(3) 
N(3)-C(21) 1.288(3) 
 
Bond angles 
O(1)-Zn(1)-O(3) 112.51(6) 
O(1)-Zn(1)-N(3) 119.48(7) 
O(3)-Zn(1)-N(3) 95.83(6) 
O(1)-Zn(1)-N(1) 97.02(6) 
O(3)-Zn(1)-N(1) 119.24(7) 
N(3)-Zn(1)-N(1) 114.35(7) 
 
 
Zn(1)-O(1) 1.9392(18) 
Zn(1)-N(1)  2.005(2) 
Zn(1)-N(2) 2.140(2) 
Zn(1)-O(3)                             2.435(2) 
Zn(1)-O(4)                             2.0027(18) 
O(1)-C(1) 1.316(3) 
N(1)-C(7) 1.273(4) 
 
 
 
O(1)-Zn(1)-O(4) 104.25(7) 
O(1)-Zn(1)-N(1) 95.03(9) 
O(4)-Zn(1)-N(1) 145.12(9) 
O(1)-Zn(1)-N(2) 121.30(9) 
O(4)-Zn(1)-N(2) 103.38(8) 
N(1)-Zn(1)-N(2) 90.46(8) 
O(1)-Zn(1)-O(3) 138.32(8) 
O(4)-Zn(1)-O(3) 58.45(7) 
N(1)-Zn(1)-O(3) 87.89(8) 
N(2)-Zn(1)-O(3) 100.20(8)  
 
Cu(1)-O(1) 1.892(2) 
Cu(1)-N(1) 2.013(3) 
O(1)-C(1) 1.306(4) 
N(1)-C(7) 1.284(4) 
 
 
 
 
 
 
O(1)-Cu(1)-O(1)#1   180.00 
O(1)-Cu(1)-N(1)                    92.56(10) 
O(1)-Cu(1)-N(1)#1                87.44(10) 
N(1)-Cu(1)-N(1)#1                180.00 
 
 
Cu(1)-O(1) 1.8883(10) 
Cu(1)-N(1) 1.9507(12) 
Cu(1)-N(2) 2.0473(12) 
Cu(1)-Cl(2) 2.2496(4) 
O(1)-C(1)                              1.3121(17) 
N(1)-C(7)                              1.2877(18) 
 
 
 
 
O(1)-Cu(1)-N(1) 94.72(5) 
O(1)-Cu(1)-N(2) 141.79(5) 
N(1)-Cu(1)-N(2) 94.36(5) 
O(1)-Cu(1)-Cl(2) 95.98(3) 
N(1)-Cu(1)-Cl(2) 141.51(4) 
N(2)-Cu(1)-Cl(2) 99.60(3) 
 
Symmetry transformations used to generate equivalent atoms: #1 -x+1,-y+2,-z+1      
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4.3 Biological studies 
4.3.1 Cytotoxicity 
The measure of cytoxicity used in this study, IC50, is the concentration required 
to reduce growth of cancer cells by 50%. Table 4.15 shows the cytotoxicity of the two 
ligands and L
1
H zinc complex on several cancer cell lines and normal cell line (IC50 
μg/ml).  
Table 4.15: The cytotoxicity of selected compounds on several cancer cell lines and 
normal cell line (IC50 μg/ml). 
Cancer cell line 
Compound 
L
1
H L
2
H [Zn(L
1
)Cl] 
WRL-68 – 5.06 – 
MCF-7 0.43 0.59 2.96 
MDA-MB-231 10.39 2.63 – 
CCD-841 9.71 18.32 – 
HT-29 0.55 2.57 14.42 
JURKAT – 4.71 – 
 WRL-68– Normal liver  
 MCF-7– Breast Cancer (+ve) 
 MDA-MB-231– Breast Cancer (–ve) 
 CCD-841– Normal Colon  
 HT-29– Colon cancer 
 JURKAT– Leukaemia 
‘–’, inactive. 
IC50 < 5.0 μg/ml – strongly active,  
IC50 5.0 < 10.0 μg/ml –moderately active,  
IC50 10.0 < 25.0 μg/ml – weakly active,  
IC50 >25.0 l μg/ml – not active.  
 
IC50 (μg/ml) = Cytotoxic dose at 50%, i.e.the concentration to reduce growth of cancer 
cells by 50%. 
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Based on this results, indicates that ligand of L
1
H exhibit strong active against 
MCF-7, breast cancer cell line and HT-29, colon cancer cell line. L
1
H ligand shows 
stronger activity against breast cancer cells with positive estrogen receptor (MCF-7) as 
compared to breast cancer cells with negative estrogen receptor (MDA-MB-231). In 
addition, L
1
H reveal inactive to normal liver cells (WRL-68) implying the ligand is 
nontoxic to the normal cell lines. Whereas, the L
2
H ligands appears to be moderately 
active against MDA-MB-231 cell lines but slightly toxic to normal liver cells. Schiff base 
ligand, L
2
H inhabits moderate activity against colon cancer cells (HT-29) and also less 
toxic to normal colon cell lines (CCD-841). This ligand also displays a moderately active 
against leukaemia disease (JURKAT).  
Furthermore, [Zn(L
1
)Cl] complex exhibit moderate active against  breast cancer 
cell line (MCF-7) and appears nontoxic to the normal liver cells. This is the only complex 
that reveals anticancer properties. All the other Schiff base complexes have low or no 
activity against the cancer cell lines.  
In conclusion, these results demonstrate that L
1
H ligand is a good inhibitor for both 
colon and breast cancer cells with IC50 of 1.10 and 0.86 μg/ml respectively. 
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4.3.2 Antioxidant - Ferric Reducing Antioxidant Power (FRAP) 
The antioxidant activities of the synthesized compounds were determined by using 
reducing power assay. This assay was carried out in triplicates and average reading was 
recorded. The figure 4.26 shows FRAP assay standard curve at absorbance 593 nm and 
figure 4.27 illustrates the FRAP value of the ligands and complexes in comparison to 
butylated hydroxytoluene (BTH), quercetin, trolox and ascorbic acid (vitamin C) as the 
standard. 
 
Figure 4.26: FRAP assay standard curve at absorbance 593 nm. 
From the data evaluation, ligand L
1
H has the highest FRAP value as compared to 
the other synthesized compounds. The L
1
H ligand has higher ferric reducing efficiency 
than the standard BTH and trolox. However, this ligand reducing ability is similar or 
slightly lower than the standard quercetin and ascorbic acid. Meanwhile, upon 
complexation of L
1
H has led to decreasing of FRAP value. On the other hand, L
2
H shows
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inferior reducing ability than L
1
H may be due the chloride substituted aromatic ring. The 
L
2
 complexes do not show any increase in the reducing power. 
 
 
Figure 4.27: FRAP value of ligands and its complexes. 
In summary, the L
1
H Schiff base ligand has the strongest potential of antioxidant 
activity. 
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5.0 CONCLUSION 
 
L
1
H and L
2
H may show ambidentate behavior in coordination to metal ions. Upon 
reactions of the Schiff bases with metal salts in a 2 : 1 ratio (ligand : metal), the ligands 
deprotonate and chelate through phenolate and imine to form the di-ligated metal 
complexes. In these complexes, morpholine nitrogen and oxygen stay away from the 
coordination spheres. Structures of the products obtained from reactions of L
2
H with metal 
salts in a 1 : 1 ratio show involvement of the morpholine nitrogen in coordination. In the 
latter complexes, L
2
 is tridentate, forming two chelate rings with the metal centres. 
Coordination environments of the metal complexes vary from square-planar to tetrahedral 
to square-pyramidal.  
The cytotoxic and antioxidant screening show that the Schiff base, L
1
H is the best 
inhibitor. Based on the IC50 results, this ligand are active against MCF-7 cells as well as, 
nontoxic to the normal liver cell lines. L
1
H also show very strong activity against HT-29 
cells but slightly toxic to the normal colon cells. Furthermore, the L
1
H have highest FRAP 
value compared to other synthesized compounds. As a conclusion, L
1
H have high potential 
as anticancer drugs and potent antioxidant activity. 
Further research on the biological application of L
1
H can be extended to in vivo 
studies. Moreover, the comprehensive studies on antioxidant application can be done by 
DPPH radical scavenging activity assay. 
The promising characteristics of the compounds as both remarkable flexidentate 
structures and biologically active have encouraged further extension into formation of 
other compound.  
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